BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ellisen LW, Bird J, West DC, Soreng AL, Reynolds TC, Smith SD, Sklar J. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell. 1991;66:649-661. [PMID: 1831692 DOI: 10.1016/0092-8674(91)90111-b] [Cited by in Crossref: 1218] [Cited by in F6Publishing: 471] [Article Influence: 39.3] [Reference Citation Analysis]
Number Citing Articles
1 Su Q, Xin L. Notch signaling in prostate cancer: refining a therapeutic opportunity. Histol Histopathol 2016;31:149-57. [PMID: 26521657 DOI: 10.14670/HH-11-685] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
2 Moore G, Annett S, McClements L, Robson T. Top Notch Targeting Strategies in Cancer: A Detailed Overview of Recent Insights and Current Perspectives. Cells 2020;9:E1503. [PMID: 32575680 DOI: 10.3390/cells9061503] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 11.5] [Reference Citation Analysis]
3 Campese AF, Garbe AI, Zhang F, Grassi F, Screpanti I, von Boehmer H. Notch1-dependent lymphomagenesis is assisted by but does not essentially require pre-TCR signaling. Blood 2006;108:305-10. [PMID: 16507772 DOI: 10.1182/blood-2006-01-0143] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 2.6] [Reference Citation Analysis]
4 Barse L, Bocchetta M. Non-small-cell lung carcinoma: role of the Notch signaling pathway. Lung Cancer (Auckl) 2015;6:43-53. [PMID: 28210150 DOI: 10.2147/LCTT.S60329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
5 Yang L, Zhang S, George SK, Teng R, You X, Xu M, Liu H, Sun X, Amin HM, Shi W. Targeting Notch1 and proteasome as an effective strategy to suppress T-cell lymphoproliferative neoplasms. Oncotarget 2015;6:14953-69. [PMID: 25879451 DOI: 10.18632/oncotarget.3621] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
6 Kumar V, Palermo R, Talora C, Campese AF, Checquolo S, Bellavia D, Tottone L, Testa G, Miele E, Indraccolo S, Amadori A, Ferretti E, Gulino A, Vacca A, Screpanti I. Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemia. Leukemia 2014;28:2324-35. [PMID: 24727676 DOI: 10.1038/leu.2014.133] [Cited by in Crossref: 102] [Cited by in F6Publishing: 107] [Article Influence: 12.8] [Reference Citation Analysis]
7 Pajerowski AG, Nguyen C, Aghajanian H, Shapiro MJ, Shapiro VS. NKAP is a transcriptional repressor of notch signaling and is required for T cell development. Immunity 2009;30:696-707. [PMID: 19409814 DOI: 10.1016/j.immuni.2009.02.011] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 4.2] [Reference Citation Analysis]
8 Nolan GP, Fujita T, Bhatia K, Huppi C, Liou HC, Scott ML, Baltimore D. The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent manner. Mol Cell Biol 1993;13:3557-66. [PMID: 8497270 DOI: 10.1128/mcb.13.6.3557-3566.1993] [Cited by in Crossref: 4] [Cited by in F6Publishing: 78] [Article Influence: 0.1] [Reference Citation Analysis]
9 Stockhausen MT, Sjölund J, Manetopoulos C, Axelson H. Effects of the histone deacetylase inhibitor valproic acid on Notch signalling in human neuroblastoma cells. Br J Cancer 2005;92:751-9. [PMID: 15685243 DOI: 10.1038/sj.bjc.6602309] [Cited by in Crossref: 86] [Cited by in F6Publishing: 84] [Article Influence: 5.1] [Reference Citation Analysis]
10 Cui H, Kong Y, Xu M, Zhang H. Notch3 functions as a tumor suppressor by controlling cellular senescence. Cancer Res 2013;73:3451-9. [PMID: 23610446 DOI: 10.1158/0008-5472.CAN-12-3902] [Cited by in Crossref: 67] [Cited by in F6Publishing: 41] [Article Influence: 7.4] [Reference Citation Analysis]
11 Milner LA, Bigas A, Kopan R, Brashem-Stein C, Bernstein ID, Martin DI. Inhibition of granulocytic differentiation by mNotch1. Proc Natl Acad Sci U S A 1996;93:13014-9. [PMID: 8917536 DOI: 10.1073/pnas.93.23.13014] [Cited by in Crossref: 145] [Cited by in F6Publishing: 144] [Article Influence: 5.6] [Reference Citation Analysis]
12 Stoyanova T, Riedinger M, Lin S, Faltermeier CM, Smith BA, Zhang KX, Going CC, Goldstein AS, Lee JK, Drake JM, Rice MA, Hsu EC, Nowroozizadeh B, Castor B, Orellana SY, Blum SM, Cheng D, Pienta KJ, Reiter RE, Pitteri SJ, Huang J, Witte ON. Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer. Proc Natl Acad Sci U S A 2016;113:E6457-66. [PMID: 27694579 DOI: 10.1073/pnas.1614529113] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
13 Kluk MJ, Ashworth T, Wang H, Knoechel B, Mason EF, Morgan EA, Dorfman D, Pinkus G, Weigert O, Hornick JL, Chirieac LR, Hirsch M, Oh DJ, South AP, Leigh IM, Pourreyron C, Cassidy AJ, Deangelo DJ, Weinstock DM, Krop IE, Dillon D, Brock JE, Lazar AJ, Peto M, Cho RJ, Stoeck A, Haines BB, Sathayanrayanan S, Rodig S, Aster JC. Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry. PLoS One 2013;8:e67306. [PMID: 23825651 DOI: 10.1371/journal.pone.0067306] [Cited by in Crossref: 76] [Cited by in F6Publishing: 68] [Article Influence: 8.4] [Reference Citation Analysis]
14 Wesley CS. Notch and wingless regulate expression of cuticle patterning genes. Mol Cell Biol 1999;19:5743-58. [PMID: 10409762 DOI: 10.1128/MCB.19.8.5743] [Cited by in Crossref: 61] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
15 Tetzlaff MT, Yu W, Li M, Zhang P, Finegold M, Mahon K, Harper JW, Schwartz RJ, Elledge SJ. Defective cardiovascular development and elevated cyclin E and Notch proteins in mice lacking the Fbw7 F-box protein. Proc Natl Acad Sci U S A 2004;101:3338-45. [PMID: 14766969 DOI: 10.1073/pnas.0307875101] [Cited by in Crossref: 176] [Cited by in F6Publishing: 180] [Article Influence: 9.8] [Reference Citation Analysis]
16 Lobry C, Oh P, Mansour MR, Look AT, Aifantis I. Notch signaling: switching an oncogene to a tumor suppressor. Blood. 2014;123:2451-2459. [PMID: 24608975 DOI: 10.1182/blood-2013-08-355818] [Cited by in Crossref: 140] [Cited by in F6Publishing: 138] [Article Influence: 17.5] [Reference Citation Analysis]
17 Hoemann CD, Beaulieu N, Girard L, Rebai N, Jolicoeur P. Two distinct Notch1 mutant alleles are involved in the induction of T-cell leukemia in c-myc transgenic mice. Mol Cell Biol 2000;20:3831-42. [PMID: 10805726 DOI: 10.1128/MCB.20.11.3831-3842.2000] [Cited by in Crossref: 67] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
18 Han M, Deng HY, Jiang R. Effect of Trastuzumab on Notch-1 Signaling Pathway in Breast Cancer SK-BR3 Cells. Chin J Cancer Res 2012;24:213-9. [PMID: 23358465 DOI: 10.1007/s11670-012-0213-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
19 Chadwick N, Zeef L, Portillo V, Fennessy C, Warrander F, Hoyle S, Buckle AM. Identification of novel Notch target genes in T cell leukaemia. Mol Cancer 2009;8:35. [PMID: 19508709 DOI: 10.1186/1476-4598-8-35] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 3.2] [Reference Citation Analysis]
20 . Retracted: Notch activation is regulated by an interaction between hCLP46 and chaperone protein calnexin. Cell Biochem Funct 2012;30:i-vi. [PMID: 22473674 DOI: 10.1002/cbf.2825] [Reference Citation Analysis]
21 Kalkat M, De Melo J, Hickman KA, Lourenco C, Redel C, Resetca D, Tamachi A, Tu WB, Penn LZ. MYC Deregulation in Primary Human Cancers. Genes (Basel) 2017;8:E151. [PMID: 28587062 DOI: 10.3390/genes8060151] [Cited by in Crossref: 146] [Cited by in F6Publishing: 120] [Article Influence: 29.2] [Reference Citation Analysis]
22 Ordentlich P, Lin A, Shen CP, Blaumueller C, Matsuno K, Artavanis-Tsakonas S, Kadesch T. Notch inhibition of E47 supports the existence of a novel signaling pathway. Mol Cell Biol 1998;18:2230-9. [PMID: 9528794 DOI: 10.1128/MCB.18.4.2230] [Cited by in Crossref: 192] [Cited by in F6Publishing: 68] [Article Influence: 8.0] [Reference Citation Analysis]
23 Louvi A, Artavanis-Tsakonas S. Notch and disease: a growing field. Semin Cell Dev Biol 2012;23:473-80. [PMID: 22373641 DOI: 10.1016/j.semcdb.2012.02.005] [Cited by in Crossref: 135] [Cited by in F6Publishing: 123] [Article Influence: 13.5] [Reference Citation Analysis]
24 Sobczuk P, Brodziak A, Khan MI, Chhabra S, Fiedorowicz M, Wełniak-Kamińska M, Synoradzki K, Bartnik E, Cudnoch-Jędrzejewska A, Czarnecka AM. Choosing The Right Animal Model for Renal Cancer Research. Transl Oncol 2020;13:100745. [PMID: 32092671 DOI: 10.1016/j.tranon.2020.100745] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
25 Qian Y, Du Z, Xing Y, Zhou T, Chen T, Shi M. Interferon regulatory factor 4 (IRF4) is overexpressed in human non‑small cell lung cancer (NSCLC) and activates the Notch signaling pathway. Mol Med Rep 2017;16:6034-40. [PMID: 28849037 DOI: 10.3892/mmr.2017.7319] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
26 Yuan L, Ma L, Xue H, Song S. Relationship between the upregulation of Notch1 signaling and the clinical characteristics of patients with papillary thyroid carcinoma in East Asia: a systematic review and meta-analysis. Cancer Cell Int 2019;19:5. [PMID: 30622441 DOI: 10.1186/s12935-018-0723-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
27 Li X, Sanda T, Look AT, Novina CD, von Boehmer H. Repression of tumor suppressor miR-451 is essential for NOTCH1-induced oncogenesis in T-ALL. J Exp Med 2011;208:663-75. [PMID: 21464222 DOI: 10.1084/jem.20102384] [Cited by in Crossref: 87] [Cited by in F6Publishing: 81] [Article Influence: 7.9] [Reference Citation Analysis]
28 Orr B, Compton DA. A double-edged sword: how oncogenes and tumor suppressor genes can contribute to chromosomal instability. Front Oncol 2013;3:164. [PMID: 23825799 DOI: 10.3389/fonc.2013.00164] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
29 Höfelmayr H, Strobl LJ, Stein C, Laux G, Marschall G, Bornkamm GW, Zimber-Strobl U. Activated mouse Notch1 transactivates Epstein-Barr virus nuclear antigen 2-regulated viral promoters. J Virol 1999;73:2770-80. [PMID: 10074124 DOI: 10.1128/JVI.73.4.2770-2780.1999] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 1.5] [Reference Citation Analysis]
30 Guarnieri AL, Towers CG, Drasin DJ, Oliphant MUJ, Andrysik Z, Hotz TJ, Vartuli RL, Linklater ES, Pandey A, Khanal S, Espinosa JM, Ford HL. The miR-106b-25 cluster mediates breast tumor initiation through activation of NOTCH1 via direct repression of NEDD4L. Oncogene 2018;37:3879-93. [PMID: 29662198 DOI: 10.1038/s41388-018-0239-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
31 Ntziachristos P, Lim JS, Sage J, Aifantis I. From fly wings to targeted cancer therapies: a centennial for notch signaling. Cancer Cell. 2014;25:318-334. [PMID: 24651013 DOI: 10.1016/j.ccr.2014.02.018] [Cited by in Crossref: 224] [Cited by in F6Publishing: 198] [Article Influence: 28.0] [Reference Citation Analysis]
32 Ramakrishnan V, Ansell S, Haug J, Grote D, Kimlinger T, Stenson M, Timm M, Wellik L, Halling T, Rajkumar SV. MRK003, a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin’s lymphoma. Leukemia. 2012;26:340-348. [PMID: 21826062 DOI: 10.1038/leu.2011.192] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 4.6] [Reference Citation Analysis]
33 Mitsiadis TA, Graf D, Luder H, Gridley T, Bluteau G. BMPs and FGFs target Notch signalling via jagged 2 to regulate tooth morphogenesis and cytodifferentiation. Development. 2010;137:3025-3035. [PMID: 20685737 DOI: 10.1242/dev.049528] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 4.3] [Reference Citation Analysis]
34 Zhang Q, Lu C, Fang T, Wang Y, Hu W, Qiao J, Liu B, Liu J, Chen N, Li M, Zhu R. Notch3 functions as a regulator of cell self-renewal by interacting with the β-catenin pathway in hepatocellular carcinoma. Oncotarget 2015;6:3669-79. [PMID: 25668819 DOI: 10.18632/oncotarget.2898] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
35 Nolan GP, Fujita T, Bhatia K, Huppi C, Liou HC, Scott ML, Baltimore D. The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent manner. Mol Cell Biol 1993;13:3557-66. [PMID: 8497270 DOI: 10.1128/mcb.13.6.3557-3566.1993] [Cited by in Crossref: 154] [Article Influence: 5.3] [Reference Citation Analysis]
36 Dahlberg A, Delaney C, Bernstein ID. Ex vivo expansion of human hematopoietic stem and progenitor cells. Blood. 2011;117:6083-6090. [PMID: 21436068 DOI: 10.1182/blood-2011-01-283606] [Cited by in Crossref: 191] [Cited by in F6Publishing: 183] [Article Influence: 17.4] [Reference Citation Analysis]
37 Hefazi M, Litzow MR. Recent Advances in the Biology and Treatment of T Cell Acute Lymphoblastic Leukemia. Curr Hematol Malig Rep 2018;13:265-74. [PMID: 29948644 DOI: 10.1007/s11899-018-0455-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
38 Hopfer O, Zwahlen D, Fey MF, Aebi S. The Notch pathway in ovarian carcinomas and adenomas. Br J Cancer 2005;93:709-18. [PMID: 16136053 DOI: 10.1038/sj.bjc.6602719] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 4.6] [Reference Citation Analysis]
39 Xing F, Okuda H, Watabe M, Kobayashi A, Pai SK, Liu W, Pandey PR, Fukuda K, Hirota S, Sugai T. Hypoxia-induced Jagged2 promotes breast cancer metastasis and self-renewal of cancer stem-like cells. Oncogene. 2011;30:4075-4086. [PMID: 21499308 DOI: 10.1038/onc.2011.122] [Cited by in Crossref: 133] [Cited by in F6Publishing: 125] [Article Influence: 12.1] [Reference Citation Analysis]
40 Hegde A, Qiu NC, Qiu X, Ho SH, Tay KQ, George J, Ng FS, Govindarajan KR, Gong Z, Mathavan S, Jiang YJ. Genomewide expression analysis in zebrafish mind bomb alleles with pancreas defects of different severity identifies putative Notch responsive genes. PLoS One 2008;3:e1479. [PMID: 18213387 DOI: 10.1371/journal.pone.0001479] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
41 Greenwald I. Notch and the awesome power of genetics. Genetics 2012;191:655-69. [PMID: 22785620 DOI: 10.1534/genetics.112.141812] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
42 Bellavia D, Campese AF, Checquolo S, Balestri A, Biondi A, Cazzaniga G, Lendahl U, Fehling HJ, Hayday AC, Frati L, von Boehmer H, Gulino A, Screpanti I. Combined expression of pTalpha and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis. Proc Natl Acad Sci U S A 2002;99:3788-93. [PMID: 11891328 DOI: 10.1073/pnas.062050599] [Cited by in Crossref: 146] [Cited by in F6Publishing: 136] [Article Influence: 7.3] [Reference Citation Analysis]
43 Tan SH, Bertulfo FC, Sanda T. Leukemia-Initiating Cells in T-Cell Acute Lymphoblastic Leukemia. Front Oncol 2017;7:218. [PMID: 29034206 DOI: 10.3389/fonc.2017.00218] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
44 Cotter M, Callahan J, Aster J, Robertson E. Intracellular forms of human NOTCH1 functionally activate essential Epstein-Barr virus major latent promoters in the Burkitt's lymphoma BJAB cell line but repress these promoters in Jurkat cells. J Virol 2000;74:1486-94. [PMID: 10627560 DOI: 10.1128/jvi.74.3.1486-1494.2000] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
45 Miles RR, Shah RK, Frazer JK. Molecular genetics of childhood, adolescent and young adult non-Hodgkin lymphoma. Br J Haematol 2016;173:582-96. [PMID: 26969846 DOI: 10.1111/bjh.14011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
46 Capaccione KM, Pine SR. The Notch signaling pathway as a mediator of tumor survival. Carcinogenesis 2013;34:1420-30. [PMID: 23585460 DOI: 10.1093/carcin/bgt127] [Cited by in Crossref: 154] [Cited by in F6Publishing: 148] [Article Influence: 17.1] [Reference Citation Analysis]
47 Wang R, Zhang H, Xu J, Zhang N, Pan T, Zhong X, Zhang H, Yin L, Yao Y, Wu Q, Li Z, Liu X, Xu K, Niu M. MALT1 Inhibition as a Therapeutic Strategy in T-Cell Acute Lymphoblastic Leukemia by Blocking Notch1-Induced NF-κB Activation. Front Oncol 2020;10:558339. [PMID: 33072583 DOI: 10.3389/fonc.2020.558339] [Reference Citation Analysis]
48 Pinchot SN, Jaskula-Sztul R, Ning L, Peters NR, Cook MR, Kunnimalaiyaan M, Chen H. Identification and validation of Notch pathway activating compounds through a novel high-throughput screening method. Cancer 2011;117:1386-98. [PMID: 21425138 DOI: 10.1002/cncr.25652] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
49 Sorrentino C, Cuneo A, Roti G. Therapeutic Targeting of Notch Signaling Pathway in Hematological Malignancies. Mediterr J Hematol Infect Dis 2019;11:e2019037. [PMID: 31308913 DOI: 10.4084/MJHID.2019.037] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
50 Kushwah R, Guezguez B, Lee JB, Hopkins CI, Bhatia M. Pleiotropic roles of Notch signaling in normal, malignant, and developmental hematopoiesis in the human. EMBO Rep 2014;15:1128-38. [PMID: 25252682 DOI: 10.15252/embr.201438842] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
51 Pajcini KV, Speck NA, Pear WS. Notch signaling in mammalian hematopoietic stem cells. Leukemia 2011;25:1525-32. [PMID: 21647159 DOI: 10.1038/leu.2011.127] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 5.2] [Reference Citation Analysis]
52 French CA, Miyoshi I, Aster JC, Kubonishi I, Kroll TG, Dal Cin P, Vargas SO, Perez-Atayde AR, Fletcher JA. BRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19). Am J Pathol 2001;159:1987-92. [PMID: 11733348 DOI: 10.1016/S0002-9440(10)63049-0] [Cited by in Crossref: 147] [Cited by in F6Publishing: 69] [Article Influence: 7.0] [Reference Citation Analysis]
53 Hsieh JJ, Henkel T, Salmon P, Robey E, Peterson MG, Hayward SD. Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2. Mol Cell Biol 1996;16:952-9. [PMID: 8622698 DOI: 10.1128/MCB.16.3.952] [Cited by in Crossref: 350] [Cited by in F6Publishing: 162] [Article Influence: 13.5] [Reference Citation Analysis]
54 Staal FJ, van Dongen JJ, Langerak AW. Novel insights into the development of T-cell acute lymphoblastic leukemia. Curr Hematol Malig Rep 2007;2:176-82. [PMID: 20425367 DOI: 10.1007/s11899-007-0024-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
55 Purow B. Notch inhibitors as a new tool in the war on cancer: a pathway to watch. Curr Pharm Biotechnol. 2009;10:154-160. [PMID: 19199947 DOI: 10.2174/138920109787315060] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
56 Harvey BM, Rana NA, Moss H, Leonardi J, Jafar-Nejad H, Haltiwanger RS. Mapping Sites of O-Glycosylation and Fringe Elongation on Drosophila Notch. J Biol Chem 2016;291:16348-60. [PMID: 27268051 DOI: 10.1074/jbc.M116.732537] [Cited by in Crossref: 40] [Cited by in F6Publishing: 23] [Article Influence: 6.7] [Reference Citation Analysis]
57 McCaw TR, Inga E, Chen H, Jaskula-Sztul R, Dudeja V, Bibb JA, Ren B, Rose JB. Gamma Secretase Inhibitors in Cancer: A Current Perspective on Clinical Performance. Oncologist 2021;26:e608-21. [PMID: 33284507 DOI: 10.1002/onco.13627] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
58 Rota R, Ciarapica R, Miele L, Locatelli F. Notch signaling in pediatric soft tissue sarcomas. BMC Med 2012;10:141. [PMID: 23158439 DOI: 10.1186/1741-7015-10-141] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
59 Dunn CD, Sulis ML, Ferrando AA, Greenwald I. A conserved tetraspanin subfamily promotes Notch signaling in Caenorhabditis elegans and in human cells. Proc Natl Acad Sci U S A 2010;107:5907-12. [PMID: 20220101 DOI: 10.1073/pnas.1001647107] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
60 Bellen HJ, Tong C, Tsuda H. 100 years of Drosophila research and its impact on vertebrate neuroscience: a history lesson for the future. Nat Rev Neurosci 2010;11:514-22. [PMID: 20383202 DOI: 10.1038/nrn2839] [Cited by in Crossref: 236] [Cited by in F6Publishing: 194] [Article Influence: 21.5] [Reference Citation Analysis]
61 Jeffries S, Robbins DJ, Capobianco AJ. Characterization of a high-molecular-weight Notch complex in the nucleus of Notch(ic)-transformed RKE cells and in a human T-cell leukemia cell line. Mol Cell Biol 2002;22:3927-41. [PMID: 11997524 DOI: 10.1128/MCB.22.11.3927-3941.2002] [Cited by in Crossref: 110] [Cited by in F6Publishing: 50] [Article Influence: 5.5] [Reference Citation Analysis]
62 Kim SH, Hahm ER, Arlotti JA, Samanta SK, Moura MB, Thorne SH, Shuai Y, Anderson CJ, White AG, Lokshin A, Lee J, Singh SV. Withaferin A inhibits in vivo growth of breast cancer cells accelerated by Notch2 knockdown. Breast Cancer Res Treat 2016;157:41-54. [PMID: 27097807 DOI: 10.1007/s10549-016-3795-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
63 Tao J, Jiang MM, Jiang L, Salvo JS, Zeng HC, Dawson B, Bertin TK, Rao PH, Chen R, Donehower LA, Gannon F, Lee BH. Notch activation as a driver of osteogenic sarcoma. Cancer Cell 2014;26:390-401. [PMID: 25203324 DOI: 10.1016/j.ccr.2014.07.023] [Cited by in Crossref: 83] [Cited by in F6Publishing: 72] [Article Influence: 10.4] [Reference Citation Analysis]
64 Estop AM, Mowery-Rushton PA, Cieply KM, Kochmar SJ, Sherer CR, Clemens M, Surti U, McPherson E. Identification of an unbalanced cryptic translocation t(9;17)(q34.3;p13.3) in a child with dysmorphic features. J Med Genet 1995;32:819-22. [PMID: 8558564 DOI: 10.1136/jmg.32.10.819] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
65 Guan Y, Wang G, Fails D, Nagarajan P, Ge Y. Unraveling cancer lineage drivers in squamous cell carcinomas. Pharmacol Ther. 2020;206:107448. [PMID: 31836455 DOI: 10.1016/j.pharmthera.2019.107448] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
66 Ansieau S, Strobl LJ, Leutz A. Activation of the Notch-regulated transcription factor CBF1/RBP-Jkappa through the 13SE1A oncoprotein. Genes Dev 2001;15:380-5. [PMID: 11230145 DOI: 10.1101/gad.189301] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
67 Zhdanovskaya N, Firrincieli M, Lazzari S, Pace E, Scribani Rossi P, Felli MP, Talora C, Screpanti I, Palermo R. Targeting Notch to Maximize Chemotherapeutic Benefits: Rationale, Advanced Strategies, and Future Perspectives. Cancers (Basel) 2021;13:5106. [PMID: 34680255 DOI: 10.3390/cancers13205106] [Reference Citation Analysis]
68 Jaskula-Sztul R, Eide J, Tesfazghi S, Dammalapati A, Harrison AD, Yu XM, Scheinebeck C, Winston-McPherson G, Kupcho KR, Robers MB, Hundal AK, Tang W, Chen H. Tumor-suppressor role of Notch3 in medullary thyroid carcinoma revealed by genetic and pharmacological induction. Mol Cancer Ther 2015;14:499-512. [PMID: 25512616 DOI: 10.1158/1535-7163.MCT-14-0073] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 3.9] [Reference Citation Analysis]
69 Sands WA, Copland M, Wheadon H. Targeting self-renewal pathways in myeloid malignancies. Cell Commun Signal 2013;11:33. [PMID: 23675967 DOI: 10.1186/1478-811X-11-33] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
70 Hannemann J, Hara T, Kawai M, Miyajima A, Ostertag W, Stocking C. Sequential mutations in the interleukin-3 (IL3)/granulocyte-macrophage colony-stimulating factor/IL5 receptor beta-subunit genes are necessary for the complete conversion to growth autonomy mediated by a truncated beta C subunit. Mol Cell Biol 1995;15:2402-12. [PMID: 7739524 DOI: 10.1128/MCB.15.5.2402] [Cited by in Crossref: 22] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
71 Pinnix CC, Lee JT, Liu ZJ, McDaid R, Balint K, Beverly LJ, Brafford PA, Xiao M, Himes B, Zabierowski SE. Active Notch1 confers a transformed phenotype to primary human melanocytes. Cancer Res. 2009;69:5312-5320. [PMID: 19549918 DOI: 10.1158/0008-5472.can-08-3767] [Cited by in Crossref: 83] [Cited by in F6Publishing: 49] [Article Influence: 6.4] [Reference Citation Analysis]
72 Milner CM, Campbell RD. The G9a gene in the human major histocompatibility complex encodes a novel protein containing ankyrin-like repeats. Biochem J 1993;290 ( Pt 3):811-8. [PMID: 8457211 DOI: 10.1042/bj2900811] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 1.6] [Reference Citation Analysis]
73 Cornejo MG, Kharas MG, Werneck MB, Le Bras S, Moore SA, Ball B, Beylot-Barry M, Rodig SJ, Aster JC, Lee BH, Cantor H, Merlio JP, Gilliland DG, Mercher T. Constitutive JAK3 activation induces lymphoproliferative syndromes in murine bone marrow transplantation models. Blood 2009;113:2746-54. [PMID: 19139084 DOI: 10.1182/blood-2008-06-164368] [Cited by in Crossref: 57] [Cited by in F6Publishing: 46] [Article Influence: 4.4] [Reference Citation Analysis]
74 Uyttendaele H, Ho J, Rossant J, Kitajewski J. Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium. Proc Natl Acad Sci U S A 2001;98:5643-8. [PMID: 11344305 DOI: 10.1073/pnas.091584598] [Cited by in Crossref: 216] [Cited by in F6Publishing: 199] [Article Influence: 10.3] [Reference Citation Analysis]
75 Takebe N, Nguyen D, Yang SX. Targeting notch signaling pathway in cancer: clinical development advances and challenges. Pharmacol Ther. 2014;141:140-149. [PMID: 24076266 DOI: 10.1016/j.pharmthera.2013.09.005] [Cited by in Crossref: 240] [Cited by in F6Publishing: 229] [Article Influence: 26.7] [Reference Citation Analysis]
76 Tang XF, Cao Y, Peng DB, Zhao GS, Zeng Y, Gao ZR, Lv YF, Guo QN. Overexpression of Notch3 is associated with metastasis and poor prognosis in osteosarcoma patients. Cancer Manag Res 2019;11:547-59. [PMID: 30662285 DOI: 10.2147/CMAR.S185495] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
77 Olsauskas-Kuprys R, Zlobin A, Osipo C. Gamma secretase inhibitors of Notch signaling. Onco Targets Ther 2013;6:943-55. [PMID: 23901284 DOI: 10.2147/OTT.S33766] [Cited by in Crossref: 27] [Cited by in F6Publishing: 67] [Article Influence: 3.0] [Reference Citation Analysis]
78 Rubio-Aliaga I, Soewarto D, Wagner S, Klaften M, Fuchs H, Kalaydjiev S, Busch DH, Klempt M, Rathkolb B, Wolf E, Abe K, Zeiser S, Przemeck GK, Beckers J, de Angelis MH. A genetic screen for modifiers of the delta1-dependent notch signaling function in the mouse. Genetics 2007;175:1451-63. [PMID: 17179084 DOI: 10.1534/genetics.106.067298] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
79 Baumgart A, Mazur PK, Anton M, Rudelius M, Schwamborn K, Feuchtinger A, Behnke K, Walch A, Braren R, Peschel C, Duyster J, Siveke JT, Dechow T. Opposing role of Notch1 and Notch2 in a Kras(G12D)-driven murine non-small cell lung cancer model. Oncogene 2015;34:578-88. [PMID: 24509876 DOI: 10.1038/onc.2013.592] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 5.9] [Reference Citation Analysis]
80 Shimizu D, Taki T, Utsunomiya A, Nakagawa H, Nomura K, Matsumoto Y, Nishida K, Horiike S, Taniwaki M. Detection of NOTCH1 mutations in adult T-cell leukemia/lymphoma and peripheral T-cell lymphoma. Int J Hematol 2007;85:212-8. [PMID: 17483057 DOI: 10.1532/IJH97.06165] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
81 Kim HK, Siu G. The notch pathway intermediate HES-1 silences CD4 gene expression. Mol Cell Biol 1998;18:7166-75. [PMID: 9819403 DOI: 10.1128/MCB.18.12.7166] [Cited by in Crossref: 62] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
82 Suman S, Das TP, Ankem MK, Damodaran C. Targeting Notch Signaling in Colorectal Cancer. Curr Colorectal Cancer Rep. 2014;10:411-416. [PMID: 25395896 DOI: 10.1007/s11888-014-0252-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
83 Vermezovic J, Adamowicz M, Santarpia L, Rustighi A, Forcato M, Lucano C, Massimiliano L, Costanzo V, Bicciato S, Del Sal G, d'Adda di Fagagna F. Notch is a direct negative regulator of the DNA-damage response. Nat Struct Mol Biol 2015;22:417-24. [PMID: 25895060 DOI: 10.1038/nsmb.3013] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 7.1] [Reference Citation Analysis]
84 Allen TD, Rodriguez EM, Jones KD, Bishop JM. Activated Notch1 induces lung adenomas in mice and cooperates with Myc in the generation of lung adenocarcinoma. Cancer Res. 2011;71:6010-6018. [PMID: 21803744 DOI: 10.1158/0008-5472.CAN-11-0595] [Cited by in Crossref: 75] [Cited by in F6Publishing: 59] [Article Influence: 6.8] [Reference Citation Analysis]
85 Ng HL, Quail E, Cruickshank MN, Ulgiati D. To Be, or Notch to Be: Mediating Cell Fate from Embryogenesis to Lymphopoiesis. Biomolecules 2021;11:849. [PMID: 34200313 DOI: 10.3390/biom11060849] [Reference Citation Analysis]
86 Wei W, Zeve D, Wang X, Du Y, Tang W, Dechow PC, Graff JM, Wan Y. Osteoclast progenitors reside in the peroxisome proliferator-activated receptor γ-expressing bone marrow cell population. Mol Cell Biol 2011;31:4692-705. [PMID: 21947280 DOI: 10.1128/MCB.05979-11] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
87 Li M, Cheng R, Liang J, Yan H, Zhang H, Yang L, Li C, Jiao Q, Lu Z, He J, Ji J, Shen Z, Li C, Hao F, Yu H, Yao Z. Mutations in POFUT1, encoding protein O-fucosyltransferase 1, cause generalized Dowling-Degos disease. Am J Hum Genet 2013;92:895-903. [PMID: 23684010 DOI: 10.1016/j.ajhg.2013.04.022] [Cited by in Crossref: 92] [Cited by in F6Publishing: 81] [Article Influence: 10.2] [Reference Citation Analysis]
88 Zhou M, Jin WY, Fan ZW, Han RC. Analysis of the expression of the Notch3 receptor protein in adult lung cancer. Oncol Lett 2013;5:499-504. [PMID: 23420695 DOI: 10.3892/ol.2012.1033] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
89 Luther KB, Schindelin H, Haltiwanger RS. Structural and mechanistic insights into lunatic fringe from a kinetic analysis of enzyme mutants. J Biol Chem 2009;284:3294-305. [PMID: 19028689 DOI: 10.1074/jbc.M805502200] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
90 Jiang R, Lan Y, Chapman HD, Shawber C, Norton CR, Serreze DV, Weinmaster G, Gridley T. Defects in limb, craniofacial, and thymic development in Jagged2 mutant mice. Genes Dev 1998;12:1046-57. [PMID: 9531541 DOI: 10.1101/gad.12.7.1046] [Cited by in Crossref: 311] [Cited by in F6Publishing: 294] [Article Influence: 13.0] [Reference Citation Analysis]
91 Kim HG, Hwang SY, Aaronson SA, Mandinova A, Lee SW. DDR1 receptor tyrosine kinase promotes prosurvival pathway through Notch1 activation. J Biol Chem 2011;286:17672-81. [PMID: 21398698 DOI: 10.1074/jbc.M111.236612] [Cited by in Crossref: 59] [Cited by in F6Publishing: 43] [Article Influence: 5.4] [Reference Citation Analysis]
92 Baloghova N, Lidak T, Cermak L. Ubiquitin Ligases Involved in the Regulation of Wnt, TGF-β, and Notch Signaling Pathways and Their Roles in Mouse Development and Homeostasis. Genes (Basel) 2019;10:E815. [PMID: 31623112 DOI: 10.3390/genes10100815] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
93 Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, Fakhry C, Xie TX, Zhang J, Wang J. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science. 2011;333:1154-1157. [PMID: 21798897 DOI: 10.1126/science.1206923] [Cited by in Crossref: 1217] [Cited by in F6Publishing: 1097] [Article Influence: 110.6] [Reference Citation Analysis]
94 Nimmagadda S, Geetha-Loganathan P, Pröls F, Scaal M, Christ B, Huang R. Expression pattern of Dll4 during chick embryogenesis. Histochem Cell Biol 2007;128:147-52. [PMID: 17605027 DOI: 10.1007/s00418-007-0306-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
95 Chu Q, Liu L, Wang W. Overexpression of hCLP46 enhances Notch activation and regulates cell proliferation in a cell type-dependent manner. Cell Prolif 2013;46:254-62. [PMID: 23692084 DOI: 10.1111/cpr.12037] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
96 Sriuranpong V, Borges MW, Strock CL, Nakakura EK, Watkins DN, Blaumueller CM, Nelkin BD, Ball DW. Notch signaling induces rapid degradation of achaete-scute homolog 1. Mol Cell Biol 2002;22:3129-39. [PMID: 11940670 DOI: 10.1128/MCB.22.9.3129-3139.2002] [Cited by in Crossref: 109] [Cited by in F6Publishing: 63] [Article Influence: 5.5] [Reference Citation Analysis]
97 Roti G, Qi J, Kitara S, Sanchez-Martin M, Saur Conway A, Varca AC, Su A, Wu L, Kung AL, Ferrando AA, Bradner JE, Stegmaier K. Leukemia-specific delivery of mutant NOTCH1 targeted therapy. J Exp Med 2018;215:197-216. [PMID: 29158376 DOI: 10.1084/jem.20151778] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
98 Rao P, Kadesch T. The intracellular form of notch blocks transforming growth factor beta-mediated growth arrest in Mv1Lu epithelial cells. Mol Cell Biol 2003;23:6694-701. [PMID: 12944493 DOI: 10.1128/MCB.23.18.6694-6701.2003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
99 Sanchez-Irizarry C, Carpenter AC, Weng AP, Pear WS, Aster JC, Blacklow SC. Notch subunit heterodimerization and prevention of ligand-independent proteolytic activation depend, respectively, on a novel domain and the LNR repeats. Mol Cell Biol 2004;24:9265-73. [PMID: 15485896 DOI: 10.1128/MCB.24.21.9265-9273.2004] [Cited by in Crossref: 142] [Cited by in F6Publishing: 79] [Article Influence: 7.9] [Reference Citation Analysis]
100 Robertson ES, Grossman S, Johannsen E, Miller C, Lin J, Tomkinson B, Kieff E. Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa. J Virol 1995;69:3108-16. [PMID: 7707539 DOI: 10.1128/JVI.69.5.3108-3116.1995] [Cited by in Crossref: 128] [Cited by in F6Publishing: 94] [Article Influence: 4.7] [Reference Citation Analysis]
101 Pece S, Serresi M, Santolini E, Capra M, Hulleman E, Galimberti V, Zurrida S, Maisonneuve P, Viale G, Di Fiore PP. Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J Cell Biol 2004;167:215-21. [PMID: 15492044 DOI: 10.1083/jcb.200406140] [Cited by in Crossref: 329] [Cited by in F6Publishing: 311] [Article Influence: 18.3] [Reference Citation Analysis]
102 Bellavia D, Campese AF, Alesse E, Vacca A, Felli MP, Balestri A, Stoppacciaro A, Tiveron C, Tatangelo L, Giovarelli M. Constitutive activation of NF-kappaB and T-cell leukemia/lymphoma in Notch3 transgenic mice. EMBO J. 2000;19:3337-3348. [PMID: 10880446 DOI: 10.1093/emboj/19.13.3337] [Cited by in Crossref: 287] [Cited by in F6Publishing: 263] [Article Influence: 13.0] [Reference Citation Analysis]
103 Yahyanejad S, Theys J, Vooijs M. Targeting Notch to overcome radiation resistance. Oncotarget 2016;7:7610-28. [PMID: 26713603 DOI: 10.18632/oncotarget.6714] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
104 Ohtsuka T, Ishibashi M, Gradwohl G, Nakanishi S, Guillemot F, Kageyama R. Hes1 and Hes5 as notch effectors in mammalian neuronal differentiation. EMBO J 1999;18:2196-207. [PMID: 10205173 DOI: 10.1093/emboj/18.8.2196] [Cited by in Crossref: 586] [Cited by in F6Publishing: 593] [Article Influence: 25.5] [Reference Citation Analysis]
105 Ma X, Renda MJ, Wang L, Cheng EC, Niu C, Morris SW, Chi AS, Krause DS. Rbm15 modulates Notch-induced transcriptional activation and affects myeloid differentiation. Mol Cell Biol 2007;27:3056-64. [PMID: 17283045 DOI: 10.1128/MCB.01339-06] [Cited by in Crossref: 58] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
106 Kalén M, Heikura T, Karvinen H, Nitzsche A, Weber H, Esser N, Ylä-Herttuala S, Hellström M. Gamma-secretase inhibitor treatment promotes VEGF-A-driven blood vessel growth and vascular leakage but disrupts neovascular perfusion. PLoS One 2011;6:e18709. [PMID: 21533193 DOI: 10.1371/journal.pone.0018709] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
107 Malecki MJ, Sanchez-Irizarry C, Mitchell JL, Histen G, Xu ML, Aster JC, Blacklow SC. Leukemia-associated mutations within the NOTCH1 heterodimerization domain fall into at least two distinct mechanistic classes. Mol Cell Biol 2006;26:4642-51. [PMID: 16738328 DOI: 10.1128/MCB.01655-05] [Cited by in Crossref: 182] [Cited by in F6Publishing: 122] [Article Influence: 11.4] [Reference Citation Analysis]
108 Fu W, Wang K, Zhao JL, Yu HC, Li SZ, Lin Y, Liang L, Huang SY, Liang YM, Han H, Qin HY. FHL1C induces apoptosis in Notch1-dependent T-ALL cells through an interaction with RBP-J. BMC Cancer 2014;14:463. [PMID: 24952875 DOI: 10.1186/1471-2407-14-463] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
109 Geissler K. Translational hematology. Wien Med Wochenschr 2014;164:487-96. [PMID: 25205187 DOI: 10.1007/s10354-014-0306-9] [Reference Citation Analysis]
110 Mack DL, Leibowitz DS, Cooper S, Ramsey H, Broxmeyer HE, Hromas R. Down-regulation of the myeloid homeobox protein Hex is essential for normal T-cell development. Immunology 2002;107:444-51. [PMID: 12460189 DOI: 10.1046/j.1365-2567.2002.01523.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
111 Ho DM, Pallavi SK, Artavanis-Tsakonas S. The Notch-mediated hyperplasia circuitry in Drosophila reveals a Src-JNK signaling axis. Elife 2015;4:e05996. [PMID: 26222204 DOI: 10.7554/eLife.05996] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 3.1] [Reference Citation Analysis]
112 Guo SS, Mi JQ, Wang J. [The role and research progress of NOTCH1 in T-cell acute lymphoblastic leukemia]. Zhonghua Xue Ye Xue Za Zhi 2021;42:165-70. [PMID: 33858050 DOI: 10.3760/cma.j.issn.0253-2727.2021.02.014] [Reference Citation Analysis]
113 Ashworth TD, Pear WS, Chiang MY, Blacklow SC, Mastio J, Xu L, Kelliher M, Kastner P, Chan S, Aster JC. Deletion-based mechanisms of Notch1 activation in T-ALL: key roles for RAG recombinase and a conserved internal translational start site in Notch1. Blood 2010;116:5455-64. [PMID: 20852131 DOI: 10.1182/blood-2010-05-286328] [Cited by in Crossref: 71] [Cited by in F6Publishing: 67] [Article Influence: 5.9] [Reference Citation Analysis]
114 Liu S, Mitra R, Zhao MM, Fan W, Eischen CM, Yin F, Zhao Z. The Potential Roles of Long Noncoding RNAs (lncRNA) in Glioblastoma Development. Mol Cancer Ther 2016;15:2977-86. [PMID: 27784795 DOI: 10.1158/1535-7163.MCT-16-0320] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
115 Deng X, Michaelson D, Tchieu J, Cheng J, Rothenstein D, Feldman R, Lee SG, Fuller J, Haimovitz-Friedman A, Studer L, Powell S, Fuks Z, Hubbard EJ, Kolesnick R. Targeting Homologous Recombination in Notch-Driven C. elegans Stem Cell and Human Tumors. PLoS One 2015;10:e0127862. [PMID: 26120834 DOI: 10.1371/journal.pone.0127862] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
116 Qiu H, Zmina PM, Huang AY, Askew D, Bedogni B. Inhibiting Notch1 enhances immunotherapy efficacy in melanoma by preventing Notch1 dependent immune suppressive properties. Cancer Lett 2018;434:144-51. [PMID: 30036609 DOI: 10.1016/j.canlet.2018.07.024] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
117 Teodorczyk M, Schmidt MHH. Notching on Cancer's Door: Notch Signaling in Brain Tumors. Front Oncol 2014;4:341. [PMID: 25601901 DOI: 10.3389/fonc.2014.00341] [Cited by in Crossref: 24] [Cited by in F6Publishing: 42] [Article Influence: 3.4] [Reference Citation Analysis]
118 Andersson ER, Lendahl U. Therapeutic modulation of Notch signalling--are we there yet? Nat Rev Drug Discov. 2014;13:357-378. [PMID: 24781550 DOI: 10.1038/nrd4252] [Cited by in Crossref: 304] [Cited by in F6Publishing: 273] [Article Influence: 38.0] [Reference Citation Analysis]
119 Maser RS, Choudhury B, Campbell PJ, Feng B, Wong KK, Protopopov A, O'Neil J, Gutierrez A, Ivanova E, Perna I, Lin E, Mani V, Jiang S, McNamara K, Zaghlul S, Edkins S, Stevens C, Brennan C, Martin ES, Wiedemeyer R, Kabbarah O, Nogueira C, Histen G, Aster J, Mansour M, Duke V, Foroni L, Fielding AK, Goldstone AH, Rowe JM, Wang YA, Look AT, Stratton MR, Chin L, Futreal PA, DePinho RA. Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers. Nature 2007;447:966-71. [PMID: 17515920 DOI: 10.1038/nature05886] [Cited by in Crossref: 274] [Cited by in F6Publishing: 284] [Article Influence: 18.3] [Reference Citation Analysis]
120 Shi W, Harris AL. Notch signaling in breast cancer and tumor angiogenesis: cross-talk and therapeutic potentials. J Mammary Gland Biol Neoplasia. 2006;11:41-52. [PMID: 16947085 DOI: 10.1007/s10911-006-9011-7] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 3.4] [Reference Citation Analysis]
121 Purow B. Notch inhibition as a promising new approach to cancer therapy. Adv Exp Med Biol. 2012;727:305-319. [PMID: 22399357 DOI: 10.1007/978-1-4614-0899-4_23] [Cited by in Crossref: 102] [Cited by in F6Publishing: 92] [Article Influence: 10.2] [Reference Citation Analysis]
122 Zagouras P, Stifani S, Blaumueller CM, Carcangiu ML, Artavanis-Tsakonas S. Alterations in Notch signaling in neoplastic lesions of the human cervix. Proc Natl Acad Sci U S A 1995;92:6414-8. [PMID: 7604005 DOI: 10.1073/pnas.92.14.6414] [Cited by in Crossref: 256] [Cited by in F6Publishing: 260] [Article Influence: 9.5] [Reference Citation Analysis]
123 Mandinova A, Lefort K, Tommasi di Vignano A, Stonely W, Ostano P, Chiorino G, Iwaki H, Nakanishi J, Dotto GP. The FoxO3a gene is a key negative target of canonical Notch signalling in the keratinocyte UVB response. EMBO J 2008;27:1243-54. [PMID: 18388864 DOI: 10.1038/emboj.2008.45] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 4.1] [Reference Citation Analysis]
124 Deftos ML, Huang E, Ojala EW, Forbush KA, Bevan MJ. Notch1 signaling promotes the maturation of CD4 and CD8 SP thymocytes. Immunity. 2000;13:73-84. [PMID: 10933396 DOI: 10.1016/s1074-7613(00)00009-1] [Cited by in Crossref: 254] [Cited by in F6Publishing: 91] [Article Influence: 11.5] [Reference Citation Analysis]
125 Evans AG, Calvi LM. Notch signaling in the malignant bone marrow microenvironment: implications for a niche-based model of oncogenesis. Ann N Y Acad Sci 2015;1335:63-77. [PMID: 25351294 DOI: 10.1111/nyas.12562] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
126 Hosseini-Alghaderi S, Baron M. Notch3 in Development, Health and Disease. Biomolecules 2020;10:E485. [PMID: 32210034 DOI: 10.3390/biom10030485] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
127 Oikawa Y, Morita KI, Kayamori K, Tanimoto K, Sakamoto K, Katoh H, Ishikawa S, Inazawa J, Harada H. Receptor tyrosine kinase amplification is predictive of distant metastasis in patients with oral squamous cell carcinoma. Cancer Sci 2017;108:256-66. [PMID: 27889930 DOI: 10.1111/cas.13126] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
128 Fang-Fang Z, You Y, Wen-Jun L. Progress in research on childhood T-cell acute lymphocytic leukemia, Notch1 signaling pathway, and its inhibitors: A review. Bosn J Basic Med Sci 2021;21:136-44. [PMID: 32415821 DOI: 10.17305/bjbms.2020.4687] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
129 Hsieh JJ, Zhou S, Chen L, Young DB, Hayward SD. CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex. Proc Natl Acad Sci USA. 1999;96:23-28. [PMID: 9874765 DOI: 10.1073/pnas.96.1.23] [Cited by in Crossref: 212] [Cited by in F6Publishing: 223] [Article Influence: 9.2] [Reference Citation Analysis]
130 Carroll KD, Bu W, Palmeri D, Spadavecchia S, Lynch SJ, Marras SA, Tyagi S, Lukac DM. Kaposi's Sarcoma-associated herpesvirus lytic switch protein stimulates DNA binding of RBP-Jk/CSL to activate the Notch pathway. J Virol 2006;80:9697-709. [PMID: 16973574 DOI: 10.1128/JVI.00746-06] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]
131 Villegas SN, Ferres-Marco D, Domínguez M. Using Drosophila Models and Tools to Understand the Mechanisms of Novel Human Cancer Driver Gene Function. Adv Exp Med Biol 2019;1167:15-35. [PMID: 31520347 DOI: 10.1007/978-3-030-23629-8_2] [Reference Citation Analysis]
132 Liu WH, Hsiao HW, Tsou WI, Lai MZ. Notch inhibits apoptosis by direct interference with XIAP ubiquitination and degradation. EMBO J 2007;26:1660-9. [PMID: 17318174 DOI: 10.1038/sj.emboj.7601611] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 3.0] [Reference Citation Analysis]
133 Lefort K, Ostano P, Mello-Grand M, Calpini V, Scatolini M, Farsetti A, Dotto GP, Chiorino G. Dual tumor suppressing and promoting function of Notch1 signaling in human prostate cancer. Oncotarget 2016;7:48011-26. [PMID: 27384993 DOI: 10.18632/oncotarget.10333] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
134 Kumar V, Vashishta M, Kong L, Wu X, Lu JJ, Guha C, Dwarakanath BS. The Role of Notch, Hedgehog, and Wnt Signaling Pathways in the Resistance of Tumors to Anticancer Therapies. Front Cell Dev Biol 2021;9:650772. [PMID: 33968932 DOI: 10.3389/fcell.2021.650772] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
135 Kopan R, Weintraub H. Mouse notch: expression in hair follicles correlates with cell fate determination. J Cell Biol 1993;121:631-41. [PMID: 8486742 DOI: 10.1083/jcb.121.3.631] [Cited by in Crossref: 112] [Cited by in F6Publishing: 116] [Article Influence: 3.9] [Reference Citation Analysis]
136 Ronchini C, Capobianco AJ. Induction of cyclin D1 transcription and CDK2 activity by Notch(ic): implication for cell cycle disruption in transformation by Notch(ic). Mol Cell Biol 2001;21:5925-34. [PMID: 11486031 DOI: 10.1128/MCB.21.17.5925-5934.2001] [Cited by in Crossref: 291] [Cited by in F6Publishing: 140] [Article Influence: 13.9] [Reference Citation Analysis]
137 Sachdev S, Hoffmann A, Hannink M. Nuclear localization of IkappaB alpha is mediated by the second ankyrin repeat: the IkappaB alpha ankyrin repeats define a novel class of cis-acting nuclear import sequences. Mol Cell Biol 1998;18:2524-34. [PMID: 9566872 DOI: 10.1128/MCB.18.5.2524] [Cited by in Crossref: 117] [Cited by in F6Publishing: 42] [Article Influence: 4.9] [Reference Citation Analysis]
138 Larmonie NS, Dik WA, Meijerink JP, Homminga I, van Dongen JJ, Langerak AW. Breakpoint sites disclose the role of the V(D)J recombination machinery in the formation of T-cell receptor (TCR) and non-TCR associated aberrations in T-cell acute lymphoblastic leukemia. Haematologica 2013;98:1173-84. [PMID: 23904235 DOI: 10.3324/haematol.2012.082156] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
139 Rand MD, Lindblom A, Carlson J, Villoutreix BO, Stenflo J. Calcium binding to tandem repeats of EGF-like modules. Expression and characterization of the EGF-like modules of human Notch-1 implicated in receptor-ligand interactions. Protein Sci 1997;6:2059-71. [PMID: 9336830 DOI: 10.1002/pro.5560061002] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 1.8] [Reference Citation Analysis]
140 Tosello V, Ferrando AA. The NOTCH signaling pathway: role in the pathogenesis of T-cell acute lymphoblastic leukemia and implication for therapy. Ther Adv Hematol 2013;4:199-210. [PMID: 23730497 DOI: 10.1177/2040620712471368] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 5.4] [Reference Citation Analysis]
141 Zarebczan B, Chen H. Signaling mechanisms in neuroendocrine tumors as targets for therapy. Endocrinol Metab Clin North Am 2010;39:801-10. [PMID: 21095546 DOI: 10.1016/j.ecl.2010.08.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
142 Dumortier A, Jeannet R, Kirstetter P, Kleinmann E, Sellars M, dos Santos NR, Thibault C, Barths J, Ghysdael J, Punt JA, Kastner P, Chan S. Notch activation is an early and critical event during T-Cell leukemogenesis in Ikaros-deficient mice. Mol Cell Biol 2006;26:209-20. [PMID: 16354692 DOI: 10.1128/MCB.26.1.209-220.2006] [Cited by in Crossref: 120] [Cited by in F6Publishing: 71] [Article Influence: 7.5] [Reference Citation Analysis]
143 Gill BS, Navgeet, Kumar S. Antioxidant potential of ganoderic acid in Notch-1 protein in neuroblastoma. Mol Cell Biochem 2019;456:1-14. [PMID: 30511344 DOI: 10.1007/s11010-018-3485-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
144 Tao J, Chen S, Yang T, Dawson B, Munivez E, Bertin T, Lee B. Osteosclerosis owing to Notch gain of function is solely Rbpj-dependent. J Bone Miner Res 2010;25:2175-83. [PMID: 20499347 DOI: 10.1002/jbmr.115] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 4.6] [Reference Citation Analysis]
145 Chu D, Wang W, Xie H, Li Y, Dong G, Xu C, Chen D, Zheng J, Li M, Lu Z, Ji G. Notch1 expression in colorectal carcinoma determines tumor differentiation status. J Gastrointest Surg. 2009;13:253-260. [PMID: 18777195 DOI: 10.1007/s11605-008-0689-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
146 Nowell CS, Radtke F. Notch as a tumour suppressor. Nat Rev Cancer 2017;17:145-59. [PMID: 28154375 DOI: 10.1038/nrc.2016.145] [Cited by in Crossref: 173] [Cited by in F6Publishing: 163] [Article Influence: 34.6] [Reference Citation Analysis]
147 Panagi M, Georgila K, Eliopoulos AG, Apidianakis Y. Constructing personalized longitudinal holo'omes of colon cancer-prone humans and their modeling in flies and mice. Oncotarget 2019;10:4224-46. [PMID: 31289620 DOI: 10.18632/oncotarget.6463] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
148 Penton AL, Leonard LD, Spinner NB. Notch signaling in human development and disease. Semin Cell Dev Biol 2012;23:450-7. [PMID: 22306179 DOI: 10.1016/j.semcdb.2012.01.010] [Cited by in Crossref: 202] [Cited by in F6Publishing: 182] [Article Influence: 20.2] [Reference Citation Analysis]
149 Yamakawa T, Atsumi Y, Kubo S, Yamagishi A, Morita I, Matsuno K. Insight into Notch Signaling Steps That Involve pecanex from Dominant-Modifier Screens in Drosophila. Genetics 2018;209:1099-119. [PMID: 29853475 DOI: 10.1534/genetics.118.300935] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
150 Vasquez-Del Carpio R, Kaplan FM, Weaver KL, VanWye JD, Alves-Guerra MC, Robbins DJ, Capobianco AJ. Assembly of a Notch transcriptional activation complex requires multimerization. Mol Cell Biol 2011;31:1396-408. [PMID: 21245387 DOI: 10.1128/MCB.00360-10] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
151 Pancewicz J, Nicot C. Current views on the role of Notch signaling and the pathogenesis of human leukemia. BMC Cancer 2011;11:502. [PMID: 22128846 DOI: 10.1186/1471-2407-11-502] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
152 Fu H, Ma C, Guan W, Cheng W, Feng F, Wang H. Expression of Notch 1 receptor associated with tumor aggressiveness in papillary thyroid carcinoma. Onco Targets Ther 2016;9:1519-23. [PMID: 27042120 DOI: 10.2147/OTT.S98239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
153 Raghu H, Gondi CS, Dinh DH, Gujrati M, Rao JS. Specific knockdown of uPA/uPAR attenuates invasion in glioblastoma cells and xenografts by inhibition of cleavage and trafficking of Notch -1 receptor. Mol Cancer. 2011;10:130. [PMID: 22004682 DOI: 10.1186/1476-4598-10-130] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 3.7] [Reference Citation Analysis]
154 Baldus CD, Thibaut J, Goekbuget N, Stroux A, Schlee C, Mossner M, Burmeister T, Schwartz S, Bloomfield CD, Hoelzer D, Thiel E, Hofmann WK. Prognostic implications of NOTCH1 and FBXW7 mutations in adult acute T-lymphoblastic leukemia. Haematologica 2009;94:1383-90. [PMID: 19794083 DOI: 10.3324/haematol.2008.005272] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 4.4] [Reference Citation Analysis]
155 Pagliaro L, Sorrentino C, Roti G. Targeting Notch Trafficking and Processing in Cancers. Cells 2020;9:E2212. [PMID: 33003595 DOI: 10.3390/cells9102212] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
156 Meisel CT, Porcheri C, Mitsiadis TA. Cancer Stem Cells, Quo Vadis? Cells. 2020;9:1879. [PMID: 32796631 DOI: 10.3390/cells9081879] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
157 Steinbuck MP, Winandy S. A Review of Notch Processing With New Insights Into Ligand-Independent Notch Signaling in T-Cells. Front Immunol 2018;9:1230. [PMID: 29910816 DOI: 10.3389/fimmu.2018.01230] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 8.0] [Reference Citation Analysis]
158 Bin Hafeez B, Adhami VM, Asim M, Siddiqui IA, Bhat KM, Zhong W, Saleem M, Din M, Setaluri V, Mukhtar H. Targeted knockdown of Notch1 inhibits invasion of human prostate cancer cells concomitant with inhibition of matrix metalloproteinase-9 and urokinase plasminogen activator. Clin Cancer Res 2009;15:452-9. [PMID: 19147749 DOI: 10.1158/1078-0432.CCR-08-1631] [Cited by in Crossref: 100] [Cited by in F6Publishing: 70] [Article Influence: 7.7] [Reference Citation Analysis]
159 Demarest RM, Dahmane N, Capobianco AJ. Notch is oncogenic dominant in T-cell acute lymphoblastic leukemia. Blood 2011;117:2901-9. [PMID: 21217079 DOI: 10.1182/blood-2010-05-286351] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
160 Balint K, Xiao M, Pinnix CC, Soma A, Veres I, Juhasz I, Brown EJ, Capobianco AJ, Herlyn M, Liu ZJ. Activation of Notch1 signaling is required for beta-catenin-mediated human primary melanoma progression. J Clin Invest 2005;115:3166-76. [PMID: 16239965 DOI: 10.1172/JCI25001] [Cited by in Crossref: 244] [Cited by in F6Publishing: 135] [Article Influence: 14.4] [Reference Citation Analysis]
161 Pierfelice TJ, Schreck KC, Eberhart CG, Gaiano N. Notch, neural stem cells, and brain tumors. Cold Spring Harb Symp Quant Biol 2008;73:367-75. [PMID: 19022772 DOI: 10.1101/sqb.2008.73.013] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 4.1] [Reference Citation Analysis]
162 Schreck KC, Taylor P, Marchionni L, Gopalakrishnan V, Bar EE, Gaiano N, Eberhart CG. The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance. Clin Cancer Res 2010;16:6060-70. [PMID: 21169257 DOI: 10.1158/1078-0432.CCR-10-1624] [Cited by in Crossref: 106] [Cited by in F6Publishing: 78] [Article Influence: 9.6] [Reference Citation Analysis]
163 Virgilio L, Narducci MG, Isobe M, Billips LG, Cooper MD, Croce CM, Russo G. Identification of the TCL1 gene involved in T-cell malignancies. Proc Natl Acad Sci U S A 1994;91:12530-4. [PMID: 7809072 DOI: 10.1073/pnas.91.26.12530] [Cited by in Crossref: 194] [Cited by in F6Publishing: 167] [Article Influence: 7.2] [Reference Citation Analysis]
164 Bash J, Zong WX, Banga S, Rivera A, Ballard DW, Ron Y, Gélinas C. Rel/NF-kappaB can trigger the Notch signaling pathway by inducing the expression of Jagged1, a ligand for Notch receptors. EMBO J. 1999;18:2803-2811. [PMID: 10329626 DOI: 10.1093/emboj/18.10.2803] [Cited by in Crossref: 148] [Cited by in F6Publishing: 149] [Article Influence: 6.4] [Reference Citation Analysis]
165 Feng Z, Xu W, Zhang C, Liu M, Wen H. Inhibition of gamma-secretase in Notch1 signaling pathway as a novel treatment for ovarian cancer. Oncotarget 2017;8:8215-25. [PMID: 28030808 DOI: 10.18632/oncotarget.14152] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
166 Hsu PJ, Yan K, Shi H, Izumchenko E, Agrawal N. Molecular biology of oral cavity squamous cell carcinoma. Oral Oncol 2020;102:104552. [PMID: 31918173 DOI: 10.1016/j.oraloncology.2019.104552] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
167 Nijjar SS, Wallace L, Crosby HA, Hubscher SG, Strain AJ. Altered Notch ligand expression in human liver disease: further evidence for a role of the Notch signaling pathway in hepatic neovascularization and biliary ductular defects. Am J Pathol 2002;160:1695-703. [PMID: 12000721 DOI: 10.1016/S0002-9440(10)61116-9] [Cited by in Crossref: 80] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
168 van Tetering G, van Diest P, Verlaan I, van der Wall E, Kopan R, Vooijs M. Metalloprotease ADAM10 is required for Notch1 site 2 cleavage. J Biol Chem 2009;284:31018-27. [PMID: 19726682 DOI: 10.1074/jbc.M109.006775] [Cited by in Crossref: 182] [Cited by in F6Publishing: 124] [Article Influence: 14.0] [Reference Citation Analysis]
169 Alsolami R, Knight SJ, Schuh A. Clinical application of targeted and genome-wide technologies: can we predict treatment responses in chronic lymphocytic leukemia? Per Med 2013;10:361-76. [PMID: 24611071 DOI: 10.2217/pme.13.33] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
170 Pavan AR, Silva GD, Jornada DH, Chiba DE, Fernandes GF, Man Chin C, Dos Santos JL. Unraveling the Anticancer Effect of Curcumin and Resveratrol. Nutrients 2016;8:E628. [PMID: 27834913 DOI: 10.3390/nu8110628] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 10.3] [Reference Citation Analysis]
171 Kalantari E, Saeidi H, Kia NS, Tahergorabi Z, Rashidi B, Dana N, Khazaei M. Effect of DAPT, a gamma secretase inhibitor, on tumor angiogenesis in control mice. Adv Biomed Res 2013;2:83. [PMID: 24520550 DOI: 10.4103/2277-9175.122498] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
172 Sethi N, Kang Y. Notch signalling in cancer progression and bone metastasis. Br J Cancer 2011;105:1805-10. [PMID: 22075946 DOI: 10.1038/bjc.2011.497] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 5.5] [Reference Citation Analysis]
173 Lecka-Czernik B, Lumpkin CK Jr, Goldstein S. An overexpressed gene transcript in senescent and quiescent human fibroblasts encoding a novel protein in the epidermal growth factor-like repeat family stimulates DNA synthesis. Mol Cell Biol 1995;15:120-8. [PMID: 7799918 DOI: 10.1128/MCB.15.1.120] [Cited by in Crossref: 78] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
174 Lampreia FP, Carmelo JG, Anjos-Afonso F. Notch Signaling in the Regulation of Hematopoietic Stem Cell. Curr Stem Cell Rep 2017;3:202-9. [PMID: 28845387 DOI: 10.1007/s40778-017-0090-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 6.6] [Reference Citation Analysis]
175 Hsieh JJ, Nofziger DE, Weinmaster G, Hayward SD. Epstein-Barr virus immortalization: Notch2 interacts with CBF1 and blocks differentiation. J Virol 1997;71:1938-45. [PMID: 9032325 DOI: 10.1128/JVI.71.3.1938-1945.1997] [Cited by in Crossref: 87] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
176 Zettl A, Ott G, Makulik A, Katzenberger T, Starostik P, Eichler T, Puppe B, Bentz M, Müller-Hermelink HK, Chott A. Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma. Am J Pathol 2002;161:1635-45. [PMID: 12414511 DOI: 10.1016/S0002-9440(10)64441-0] [Cited by in Crossref: 115] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
177 Brandstadter JD, Maillard I. Notch signalling in T cell homeostasis and differentiation. Open Biol 2019;9:190187. [PMID: 31690218 DOI: 10.1098/rsob.190187] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
178 Rosati E, Baldoni S, De Falco F, Del Papa B, Dorillo E, Rompietti C, Albi E, Falzetti F, Di Ianni M, Sportoletti P. NOTCH1 Aberrations in Chronic Lymphocytic Leukemia. Front Oncol 2018;8:229. [PMID: 29998084 DOI: 10.3389/fonc.2018.00229] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
179 Ono M, Takimoto R, Osuga T, Okagawa Y, Hirakawa M, Yoshida M, Arihara Y, Uemura N, Hayasaka N, Miura S, Matsuno T, Tamura F, Sato Y, Sato T, Iyama S, Miyanishi K, Takada K, Kobune M, Kato J. Targeting Notch-1 positive acute leukemia cells by novel fucose-bound liposomes carrying daunorubicin. Oncotarget 2016;7:38586-97. [PMID: 27233074 DOI: 10.18632/oncotarget.9558] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
180 Kobia FM, Preusse K, Dai Q, Weaver N, Hass MR, Chaturvedi P, Stein SJ, Pear WS, Yuan Z, Kovall RA, Kuang Y, Eafergen N, Sprinzak D, Gebelein B, Brunskill EW, Kopan R. Notch dimerization and gene dosage are important for normal heart development, intestinal stem cell maintenance, and splenic marginal zone B-cell homeostasis during mite infestation. PLoS Biol 2020;18:e3000850. [PMID: 33017398 DOI: 10.1371/journal.pbio.3000850] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
181 Harada S, Kieff E. Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation. J Virol 1997;71:6611-8. [PMID: 9261383 DOI: 10.1128/JVI.71.9.6611-6618.1997] [Cited by in Crossref: 131] [Cited by in F6Publishing: 89] [Article Influence: 5.2] [Reference Citation Analysis]
182 McIntyre B, Asahara T, Alev C. Overview of Basic Mechanisms of Notch Signaling in Development and Disease. Adv Exp Med Biol 2020;1227:9-27. [PMID: 32072496 DOI: 10.1007/978-3-030-36422-9_2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
183 Williams CK, Li JL, Murga M, Harris AL, Tosato G. Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function. Blood 2006;107:931-9. [PMID: 16219802 DOI: 10.1182/blood-2005-03-1000] [Cited by in Crossref: 260] [Cited by in F6Publishing: 254] [Article Influence: 15.3] [Reference Citation Analysis]
184 Bongiovanni D, Saccomani V, Piovan E. Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia. Int J Mol Sci 2017;18:E1904. [PMID: 28872614 DOI: 10.3390/ijms18091904] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
185 Ren M, Cowell JK. Constitutive Notch pathway activation in murine ZMYM2-FGFR1-induced T-cell lymphomas associated with atypical myeloproliferative disease. Blood 2011;117:6837-47. [PMID: 21527531 DOI: 10.1182/blood-2010-07-295725] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
186 Grochowski CM, Loomes KM, Spinner NB. Jagged1 (JAG1): Structure, expression, and disease associations. Gene 2016;576:381-4. [PMID: 26548814 DOI: 10.1016/j.gene.2015.10.065] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 8.6] [Reference Citation Analysis]
187 Engel I, Murre C. Disruption of pre-TCR expression accelerates lymphomagenesis in E2A-deficient mice. Proc Natl Acad Sci U S A 2002;99:11322-7. [PMID: 12172006 DOI: 10.1073/pnas.162373999] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 1.8] [Reference Citation Analysis]
188 Wu L, Sun T, Kobayashi K, Gao P, Griffin JD. Identification of a family of mastermind-like transcriptional coactivators for mammalian notch receptors. Mol Cell Biol. 2002;22:7688-7700. [PMID: 12370315 DOI: 10.1128/mcb.22.21.7688-7700.2002] [Cited by in Crossref: 175] [Cited by in F6Publishing: 85] [Article Influence: 8.8] [Reference Citation Analysis]
189 Stockhausen MT, Kristoffersen K, Poulsen HS. The functional role of Notch signaling in human gliomas. Neuro Oncol 2010;12:199-211. [PMID: 20150387 DOI: 10.1093/neuonc/nop022] [Cited by in Crossref: 75] [Cited by in F6Publishing: 72] [Article Influence: 5.8] [Reference Citation Analysis]
190 Park YH, Kim SJ, Jeong BH, Herzog TJ, Wright J, Kitajewski J, Rhim CC, Jang PR, Kang JB, Kim SJ. Follicular stimulating hormone enhances Notch 1 expression in SK-OV-3 ovarian cancer cells. J Gynecol Oncol 2010;21:119-24. [PMID: 20613903 DOI: 10.3802/jgo.2010.21.2.119] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
191 Hubbard EJ, Wu G, Kitajewski J, Greenwald I. sel-10, a negative regulator of lin-12 activity in Caenorhabditis elegans, encodes a member of the CDC4 family of proteins. Genes Dev 1997;11:3182-93. [PMID: 9389650 DOI: 10.1101/gad.11.23.3182] [Cited by in Crossref: 171] [Cited by in F6Publishing: 172] [Article Influence: 7.1] [Reference Citation Analysis]
192 Lin YW, Deveney R, Barbara M, Iscove NN, Nimer SD, Slape C, Aplan PD. OLIG2 (BHLHB1), a bHLH transcription factor, contributes to leukemogenesis in concert with LMO1. Cancer Res 2005;65:7151-8. [PMID: 16103065 DOI: 10.1158/0008-5472.CAN-05-1400] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
193 Hamidi H, Gustafason D, Pellegrini M, Gasson J. Identification of novel targets of CSL-dependent Notch signaling in hematopoiesis. PLoS One 2011;6:e20022. [PMID: 21637838 DOI: 10.1371/journal.pone.0020022] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
194 Banerjee D, Kadenhe-Chiweshe A, Yamashiro DJ. Inhibition of Notch promotes liver metastasis. Aging (Albany NY) 2015;7:603-4. [PMID: 26399554 DOI: 10.18632/aging.100811] [Reference Citation Analysis]
195 Park JT, Shih IeM, Wang TL. Identification of Pbx1, a potential oncogene, as a Notch3 target gene in ovarian cancer. Cancer Res 2008;68:8852-60. [PMID: 18974129 DOI: 10.1158/0008-5472.CAN-08-0517] [Cited by in Crossref: 44] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
196 Wakabayashi N, Chartoumpekis DV, Kensler TW. Crosstalk between Nrf2 and Notch signaling. Free Radic Biol Med 2015;88:158-67. [PMID: 26003520 DOI: 10.1016/j.freeradbiomed.2015.05.017] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 7.6] [Reference Citation Analysis]
197 Qu J, Song M, Xie J, Huang XY, Hu XM, Gan RH, Zhao Y, Lin LS, Chen J, Lin X, Zheng DL, Lu YG. Notch2 signaling contributes to cell growth, invasion, and migration in salivary adenoid cystic carcinoma. Mol Cell Biochem 2016;411:135-41. [PMID: 26427670 DOI: 10.1007/s11010-015-2575-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
198 Lan K, Verma SC, Murakami M, Bajaj B, Kaul R, Robertson ES. Kaposi's sarcoma herpesvirus-encoded latency-associated nuclear antigen stabilizes intracellular activated Notch by targeting the Sel10 protein. Proc Natl Acad Sci U S A 2007;104:16287-92. [PMID: 17909182 DOI: 10.1073/pnas.0703508104] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 2.6] [Reference Citation Analysis]
199 Spinner NB. CADASIL: Notch signaling defect or protein accumulation problem? J Clin Invest 2000;105:561-2. [PMID: 10712425 DOI: 10.1172/JCI9511] [Cited by in Crossref: 29] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
200 Sullivan JT, Fraser KM, Fleming SB, Robinson AJ, Mercer AA. Sequence and transcriptional analysis of an orf virus gene encoding ankyrin-like repeat sequences. Virus Genes 1995;9:277-82. [PMID: 7597806 DOI: 10.1007/BF01702883] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
201 Yu XM, Jaskula-Sztul R, Georgen MR, Aburjania Z, Somnay YR, Leverson G, Sippel RS, Lloyd RV, Johnson BP, Chen H. Notch1 Signaling Regulates the Aggressiveness of Differentiated Thyroid Cancer and Inhibits SERPINE1 Expression. Clin Cancer Res 2016;22:3582-92. [PMID: 26847059 DOI: 10.1158/1078-0432.CCR-15-1749] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
202 Kummar S, O'Sullivan Coyne G, Do KT, Turkbey B, Meltzer PS, Polley E, Choyke PL, Meehan R, Vilimas R, Horneffer Y, Juwara L, Lih A, Choudhary A, Mitchell SA, Helman LJ, Doroshow JH, Chen AP. Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis). J Clin Oncol 2017;35:1561-9. [PMID: 28350521 DOI: 10.1200/JCO.2016.71.1994] [Cited by in Crossref: 69] [Cited by in F6Publishing: 37] [Article Influence: 13.8] [Reference Citation Analysis]
203 Wendorff AA, Ferrando AA. Modeling NOTCH1 driven T-cell Acute Lymphoblastic Leukemia in Mice. Bio Protoc 2020;10:e3620. [PMID: 33659293 DOI: 10.21769/BioProtoc.3620] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
204 Egloff AM, Grandis JR. Molecular pathways: context-dependent approaches to Notch targeting as cancer therapy. Clin Cancer Res 2012;18:5188-95. [PMID: 22773520 DOI: 10.1158/1078-0432.CCR-11-2258] [Cited by in Crossref: 45] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
205 Burns CE, Traver D, Mayhall E, Shepard JL, Zon LI. Hematopoietic stem cell fate is established by the Notch-Runx pathway. Genes Dev 2005;19:2331-42. [PMID: 16166372 DOI: 10.1101/gad.1337005] [Cited by in Crossref: 298] [Cited by in F6Publishing: 288] [Article Influence: 17.5] [Reference Citation Analysis]
206 Copeland NG, Jenkins NA. Harnessing transposons for cancer gene discovery. Nat Rev Cancer 2010;10:696-706. [PMID: 20844553 DOI: 10.1038/nrc2916] [Cited by in Crossref: 124] [Cited by in F6Publishing: 107] [Article Influence: 10.3] [Reference Citation Analysis]
207 Moellering RE, Cornejo M, Davis TN, Del Bianco C, Aster JC, Blacklow SC, Kung AL, Gilliland DG, Verdine GL, Bradner JE. Direct inhibition of the NOTCH transcription factor complex. Nature 2009;462:182-8. [PMID: 19907488 DOI: 10.1038/nature08543] [Cited by in Crossref: 568] [Cited by in F6Publishing: 541] [Article Influence: 47.3] [Reference Citation Analysis]
208 Hassan WA, Takebayashi SI, Abdalla MOA, Fujino K, Kudoh S, Motooka Y, Sato Y, Naito Y, Higaki K, Wakimoto J, Okada S, Nakao M, Ishikawa Y, Ito T. Correlation between histone acetylation and expression of Notch1 in human lung carcinoma and its possible role in combined small-cell lung carcinoma. Lab Invest 2017;97:913-21. [PMID: 28414324 DOI: 10.1038/labinvest.2017.36] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
209 Li X, von Boehmer H. Notch Signaling in T-Cell Development and T-ALL. ISRN Hematol 2011;2011:921706. [PMID: 22111016 DOI: 10.5402/2011/921706] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
210 Zhang Y, Gundelach J, Lindquist LD, Baker DJ, van Deursen J, Bram RJ. Chemotherapy-induced cellular senescence suppresses progression of Notch-driven T-ALL. PLoS One 2019;14:e0224172. [PMID: 31661505 DOI: 10.1371/journal.pone.0224172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
211 Loyo M, Li RJ, Bettegowda C, Pickering CR, Frederick MJ, Myers JN, Agrawal N. Lessons learned from next-generation sequencing in head and neck cancer. Head Neck. 2013;35:454-463. [PMID: 22907887 DOI: 10.1002/hed.23100] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
212 Carvalho FL, Simons BW, Eberhart CG, Berman DM. Notch signaling in prostate cancer: a moving target. Prostate 2014;74:933-45. [PMID: 24737393 DOI: 10.1002/pros.22811] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 5.9] [Reference Citation Analysis]
213 Schwanbeck R, Just U. The Notch signaling pathway in hematopoiesis and hematologic malignancies. Haematologica 2011;96:1735-7. [PMID: 22147769 DOI: 10.3324/haematol.2011.055954] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
214 Aster JC, Blacklow SC, Pear WS. Notch signalling in T-cell lymphoblastic leukaemia/lymphoma and other haematological malignancies. J Pathol 2011;223:262-73. [PMID: 20967796 DOI: 10.1002/path.2789] [Cited by in Crossref: 109] [Cited by in F6Publishing: 105] [Article Influence: 9.1] [Reference Citation Analysis]
215 Reschly EJ, Spaulding C, Vilimas T, Graham WV, Brumbaugh RL, Aifantis I, Pear WS, Kee BL. Notch1 promotes survival of E2A-deficient T cell lymphomas through pre-T cell receptor-dependent and -independent mechanisms. Blood 2006;107:4115-21. [PMID: 16449526 DOI: 10.1182/blood-2005-09-3551] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
216 Talora C, Sgroi DC, Crum CP, Dotto GP. Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation. Genes Dev 2002;16:2252-63. [PMID: 12208848 DOI: 10.1101/gad.988902] [Cited by in Crossref: 176] [Cited by in F6Publishing: 176] [Article Influence: 8.8] [Reference Citation Analysis]
217 Jeannet R, Mastio J, Macias-Garcia A, Oravecz A, Ashworth T, Geimer Le Lay AS, Jost B, Le Gras S, Ghysdael J, Gridley T, Honjo T, Radtke F, Aster JC, Chan S, Kastner P. Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALL. Blood 2010;116:5443-54. [PMID: 20829372 DOI: 10.1182/blood-2010-05-286658] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 5.1] [Reference Citation Analysis]
218 Guenter R, Patel Z, Chen H. Notch Signaling in Thyroid Cancer. Adv Exp Med Biol 2021;1287:155-68. [PMID: 33034031 DOI: 10.1007/978-3-030-55031-8_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
219 Brzozowa-Zasada M, Piecuch A, Michalski M, Segiet O, Kurek J, Harabin-Słowińska M, Wojnicz R. Notch and its oncogenic activity in human malignancies. Eur Surg 2017;49:199-209. [PMID: 29104587 DOI: 10.1007/s10353-017-0491-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
220 Lee L, Dowhanick-Morrissette J, Katz A, Jukofsky L, Krantz ID. Chromosomal localization, genomic characterization, and mapping to the Noonan syndrome critical region of the human Deltex (DTX1) gene. Hum Genet 2000;107:577-81. [PMID: 11153911 DOI: 10.1007/s004390000431] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
221 Fernandez-Valdivia R, Takeuchi H, Samarghandi A, Lopez M, Leonardi J, Haltiwanger RS, Jafar-Nejad H. Regulation of mammalian Notch signaling and embryonic development by the protein O-glucosyltransferase Rumi. Development. 2011;138:1925-1934. [PMID: 21490058 DOI: 10.1242/dev.060020] [Cited by in Crossref: 118] [Cited by in F6Publishing: 103] [Article Influence: 10.7] [Reference Citation Analysis]
222 Rogers JM, Guo B, Egan ED, Aster JC, Adelman K, Blacklow SC. MAML1-Dependent Notch-Responsive Genes Exhibit Differing Cofactor Requirements for Transcriptional Activation. Mol Cell Biol 2020;40:e00014-20. [PMID: 32179552 DOI: 10.1128/MCB.00014-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
223 Mitsiadis TA, Lardelli M, Lendahl U, Thesleff I. Expression of Notch 1, 2 and 3 is regulated by epithelial-mesenchymal interactions and retinoic acid in the developing mouse tooth and associated with determination of ameloblast cell fate. J Cell Biol 1995;130:407-18. [PMID: 7615640 DOI: 10.1083/jcb.130.2.407] [Cited by in Crossref: 141] [Cited by in F6Publishing: 126] [Article Influence: 5.2] [Reference Citation Analysis]
224 Sarmento LM, Huang H, Limon A, Gordon W, Fernandes J, Tavares MJ, Miele L, Cardoso AA, Classon M, Carlesso N. Notch1 modulates timing of G1-S progression by inducing SKP2 transcription and p27 Kip1 degradation. J Exp Med 2005;202:157-68. [PMID: 15998794 DOI: 10.1084/jem.20050559] [Cited by in Crossref: 137] [Cited by in F6Publishing: 120] [Article Influence: 8.1] [Reference Citation Analysis]
225 Shah PA, Huang C, Li Q, Kazi SA, Byers LA, Wang J, Johnson FM, Frederick MJ. NOTCH1 Signaling in Head and Neck Squamous Cell Carcinoma. Cells 2020;9:E2677. [PMID: 33322834 DOI: 10.3390/cells9122677] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
226 Gray GE, Mann RS, Mitsiadis E, Henrique D, Carcangiu ML, Banks A, Leiman J, Ward D, Ish-Horowitz D, Artavanis-Tsakonas S. Human ligands of the Notch receptor. Am J Pathol 1999;154:785-94. [PMID: 10079256 DOI: 10.1016/S0002-9440(10)65325-4] [Cited by in Crossref: 132] [Cited by in F6Publishing: 35] [Article Influence: 5.7] [Reference Citation Analysis]
227 Mitsiadis TA. Emerging Trends and Promises in Orofacial Cancers. Front Physiol 2019;10:679. [PMID: 31191362 DOI: 10.3389/fphys.2019.00679] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
228 Gordadze AV, Peng R, Tan J, Liu G, Sutton R, Kempkes B, Bornkamm GW, Ling PD. Notch1IC partially replaces EBNA2 function in B cells immortalized by Epstein-Barr virus. J Virol 2001;75:5899-912. [PMID: 11390591 DOI: 10.1128/JVI.75.13.5899-5912.2001] [Cited by in Crossref: 49] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
229 Knoechel B, Roderick JE, Williamson KE, Zhu J, Lohr JG, Cotton MJ, Gillespie SM, Fernandez D, Ku M, Wang H, Piccioni F, Silver SJ, Jain M, Pearson D, Kluk MJ, Ott CJ, Shultz LD, Brehm MA, Greiner DL, Gutierrez A, Stegmaier K, Kung AL, Root DE, Bradner JE, Aster JC, Kelliher MA, Bernstein BE. An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia. Nat Genet 2014;46:364-70. [PMID: 24584072 DOI: 10.1038/ng.2913] [Cited by in Crossref: 249] [Cited by in F6Publishing: 218] [Article Influence: 31.1] [Reference Citation Analysis]
230 Tao J, Chen S, Lee B. Alteration of Notch signaling in skeletal development and disease. Ann N Y Acad Sci 2010;1192:257-68. [PMID: 20392245 DOI: 10.1111/j.1749-6632.2009.05307.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 3.6] [Reference Citation Analysis]
231 Elagib KE, Xiao M, Hussaini IM, Delehanty LL, Palmer LA, Racke FK, Birrer MJ, Ganapathy-Kanniappan S, McDevitt MA, Goldfarb AN. Jun blockade of erythropoiesis: role for repression of GATA-1 by HERP2. Mol Cell Biol 2004;24:7779-94. [PMID: 15314183 DOI: 10.1128/MCB.24.17.7779-7794.2004] [Cited by in Crossref: 51] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
232 Sakai T, Taniguchi Y, Tamura K, Minoguchi S, Fukuhara T, Strobl LJ, Zimber-Strobl U, Bornkamm GW, Honjo T. Functional replacement of the intracellular region of the Notch1 receptor by Epstein-Barr virus nuclear antigen 2. J Virol 1998;72:6034-9. [PMID: 9621066 DOI: 10.1128/JVI.72.7.6034-6039.1998] [Cited by in Crossref: 55] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
233 Li GH, Fan YZ, Liu XW, Zhang BF, Yin DD, He F, Huang SY, Kang ZJ, Xu H, Liu Q, Wu YL, Niu XL, Zhang L, Liu L, Hao MW, Han H, Liang YM. Notch signaling maintains proliferation and survival of the HL60 human promyelocytic leukemia cell line and promotes the phosphorylation of the Rb protein. Mol Cell Biochem 2010;340:7-14. [PMID: 20157766 DOI: 10.1007/s11010-010-0394-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
234 Rampal R, Arboleda-Velasquez JF, Nita-Lazar A, Kosik KS, Haltiwanger RS. Highly conserved O-fucose sites have distinct effects on Notch1 function. J Biol Chem 2005;280:32133-40. [PMID: 15994302 DOI: 10.1074/jbc.M506104200] [Cited by in Crossref: 84] [Cited by in F6Publishing: 46] [Article Influence: 4.9] [Reference Citation Analysis]
235 Jia H, Zhang K, Chen Q, Gao H, Wang W. Downregulation of Notch-1/Jagged-2 in human colon tissues from Hirschsprung disease patients. Int J Colorectal Dis 2012;27:37-41. [PMID: 21892607 DOI: 10.1007/s00384-011-1295-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
236 Kannan S, Sutphin RM, Hall MG, Golfman LS, Fang W, Nolo RM, Akers LJ, Hammitt RA, McMurray JS, Kornblau SM, Melnick AM, Figueroa ME, Zweidler-McKay PA. Notch activation inhibits AML growth and survival: A potential therapeutic approach. J Exp Med. 2013;210:321-337. [PMID: 23359069 DOI: 10.1084/jem.20121527] [Cited by in Crossref: 93] [Cited by in F6Publishing: 88] [Article Influence: 10.3] [Reference Citation Analysis]
237 Boulay JL, Miserez AR, Zweifel C, Sivasankaran B, Kana V, Ghaffari A, Luyken C, Sabel M, Zerrouqi A, Wasner M, Van Meir E, Tolnay M, Reifenberger G, Merlo A. Loss of NOTCH2 positively predicts survival in subgroups of human glial brain tumors. PLoS One 2007;2:e576. [PMID: 17593975 DOI: 10.1371/journal.pone.0000576] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
238 Zhao B, Sample CE. Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site. J Virol 2000;74:5151-60. [PMID: 10799590 DOI: 10.1128/jvi.74.11.5151-5160.2000] [Cited by in Crossref: 86] [Cited by in F6Publishing: 66] [Article Influence: 3.9] [Reference Citation Analysis]
239 Pierfelice TJ, Schreck KC, Dang L, Asnaghi L, Gaiano N, Eberhart CG. Notch3 activation promotes invasive glioma formation in a tissue site-specific manner. Cancer Res 2011;71:1115-25. [PMID: 21245095 DOI: 10.1158/0008-5472.CAN-10-0690] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
240 Sun Y, Klauzinska M, Lake RJ, Lee JM, Santopietro S, Raafat A, Salomon D, Callahan R, Artavanis-Tsakonas S. Trp53 regulates Notch 4 signaling through Mdm2. J Cell Sci 2011;124:1067-76. [PMID: 21402876 DOI: 10.1242/jcs.068965] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
241 Thounaojam MC, Dudimah DF, Pellom ST Jr, Uzhachenko RV, Carbone DP, Dikov MM, Shanker A. Bortezomib enhances expression of effector molecules in anti-tumor CD8+ T lymphocytes by promoting Notch-nuclear factor-κB crosstalk. Oncotarget 2015;6:32439-55. [PMID: 26431276 DOI: 10.18632/oncotarget.5857] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
242 de Oliveira-Carlos V, Ganz J, Hans S, Kaslin J, Brand M. Notch receptor expression in neurogenic regions of the adult zebrafish brain. PLoS One 2013;8:e73384. [PMID: 24039926 DOI: 10.1371/journal.pone.0073384] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
243 Herrick DB, Guo Z, Jang W, Schnittke N, Schwob JE. Canonical Notch Signaling Directs the Fate of Differentiating Neurocompetent Progenitors in the Mammalian Olfactory Epithelium. J Neurosci 2018;38:5022-37. [PMID: 29739871 DOI: 10.1523/JNEUROSCI.0484-17.2018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
244 Johannsen E, Miller CL, Grossman SR, Kieff E. EBNA-2 and EBNA-3C extensively and mutually exclusively associate with RBPJkappa in Epstein-Barr virus-transformed B lymphocytes. J Virol 1996;70:4179-83. [PMID: 8648764 DOI: 10.1128/JVI.70.6.4179-4183.1996] [Cited by in Crossref: 77] [Cited by in F6Publishing: 57] [Article Influence: 3.0] [Reference Citation Analysis]
245 Cortegano I, Melgar-Rojas P, Luna-Zurita L, Siguero-Álvarez M, Marcos MA, Gaspar ML, de la Pompa JL. Notch1 regulates progenitor cell proliferation and differentiation during mouse yolk sac hematopoiesis. Cell Death Differ 2014;21:1081-94. [PMID: 24583642 DOI: 10.1038/cdd.2014.27] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
246 Ghanbari-Movahed M, Ghanbari-Movahed Z, Momtaz S, Kilpatrick KL, Farzaei MH, Bishayee A. Unlocking the Secrets of Cancer Stem Cells with γ-Secretase Inhibitors: A Novel Anticancer Strategy. Molecules 2021;26:972. [PMID: 33673088 DOI: 10.3390/molecules26040972] [Reference Citation Analysis]
247 Ranganathan P, Vasquez-Del Carpio R, Kaplan FM, Wang H, Gupta A, VanWye JD, Capobianco AJ. Hierarchical phosphorylation within the ankyrin repeat domain defines a phosphoregulatory loop that regulates Notch transcriptional activity. J Biol Chem 2011;286:28844-57. [PMID: 21685388 DOI: 10.1074/jbc.M111.243600] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
248 Paryan M, Mohammadi-Yeganeh S, Samiee SM, Soleimani M, Arefian E, Azadmanesh K, Poopak B, Mostafavi E, Karimipoor M, Mahdian R. Investigation of deregulated genes of Notch signaling pathway in human T cell acute lymphoblastic leukemia cell lines and clinical samples. Mol Biol Rep 2013;40:5531-40. [PMID: 23982259 DOI: 10.1007/s11033-013-2654-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
249 Lan K, Choudhuri T, Murakami M, Kuppers DA, Robertson ES. Intracellular activated Notch1 is critical for proliferation of Kaposi's sarcoma-associated herpesvirus-associated B-lymphoma cell lines in vitro. J Virol 2006;80:6411-9. [PMID: 16775329 DOI: 10.1128/JVI.00239-06] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
250 Chiang MY, Pear WS. Cancer genetics: activated notch takes center stage in T-cell leukemogenesis. Eur J Hum Genet 2005;13:393-5. [PMID: 15702128 DOI: 10.1038/sj.ejhg.5201380] [Reference Citation Analysis]
251 Cejkova P, Zettl A, Baumgärtner AK, Chott A, Ott G, Müller-Hermelink HK, Starostik P. Amplification of NOTCH1 and ABL1 gene loci is a frequent aberration in enteropathy-type T-cell lymphoma. Virchows Arch 2005;446:416-20. [PMID: 15756589 DOI: 10.1007/s00428-005-1214-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
252 Bolós V, Mira E, Martínez-Poveda B, Luxán G, Cañamero M, Martínez-A C, Mañes S, de la Pompa JL. Notch activation stimulates migration of breast cancer cells and promotes tumor growth. Breast Cancer Res 2013;15:R54. [PMID: 23826634 DOI: 10.1186/bcr3447] [Cited by in Crossref: 80] [Cited by in F6Publishing: 78] [Article Influence: 10.0] [Reference Citation Analysis]
253 Wang HC, Peng V, Zhao Y, Sun XH. Enhanced Notch activation is advantageous but not essential for T cell lymphomagenesis in Id1 transgenic mice. PLoS One 2012;7:e32944. [PMID: 22393458 DOI: 10.1371/journal.pone.0032944] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
254 Tamagnone L, Zacchigna S, Rehman M. Taming the Notch Transcriptional Regulator for Cancer Therapy. Molecules 2018;23:E431. [PMID: 29462871 DOI: 10.3390/molecules23020431] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
255 Palomero T, Lim WK, Odom DT, Sulis ML, Real PJ, Margolin A, Barnes KC, O'Neil J, Neuberg D, Weng AP, Aster JC, Sigaux F, Soulier J, Look AT, Young RA, Califano A, Ferrando AA. NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci U S A 2006;103:18261-6. [PMID: 17114293 DOI: 10.1073/pnas.0606108103] [Cited by in Crossref: 561] [Cited by in F6Publishing: 545] [Article Influence: 35.1] [Reference Citation Analysis]
256 Mori M, Miyamoto T, Yakushiji H, Ohno S, Miyake Y, Sakaguchi T, Hattori M, Hongo A, Nakaizumi A, Ueda M, Ohno E. Effects of N-[N-(3, 5-difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester (DAPT) on cell proliferation and apoptosis in Ishikawa endometrial cancer cells. Hum Cell 2012;25:9-15. [PMID: 22189483 DOI: 10.1007/s13577-011-0038-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
257 Chan AC, Smeets MF, Izon DJ. An in vivo functional genetic screen for suppressors of the Rag1-/- T-cell defect. Mol Immunol 2008;45:682-9. [PMID: 17826832 DOI: 10.1016/j.molimm.2007.07.017] [Reference Citation Analysis]
258 Wang J, Jani-Sait SN, Escalon EA, Carroll AJ, de Jong PJ, Kirsch IR, Aplan PD. The t(14;21)(q11.2;q22) chromosomal translocation associated with T-cell acute lymphoblastic leukemia activates the BHLHB1 gene. Proc Natl Acad Sci U S A 2000;97:3497-502. [PMID: 10737801 DOI: 10.1073/pnas.97.7.3497] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 2.8] [Reference Citation Analysis]
259 Chiang MY, Xu L, Shestova O, Histen G, L'heureux S, Romany C, Childs ME, Gimotty PA, Aster JC, Pear WS. Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras-initiated leukemia. J Clin Invest 2008;118:3181-94. [PMID: 18677410 DOI: 10.1172/JCI35090] [Cited by in Crossref: 166] [Cited by in F6Publishing: 121] [Article Influence: 11.9] [Reference Citation Analysis]
260 Lu FM, Lux SE. Constitutively active human Notch1 binds to the transcription factor CBF1 and stimulates transcription through a promoter containing a CBF1-responsive element. Proc Natl Acad Sci U S A 1996;93:5663-7. [PMID: 8643633 DOI: 10.1073/pnas.93.11.5663] [Cited by in Crossref: 61] [Cited by in F6Publishing: 67] [Article Influence: 2.3] [Reference Citation Analysis]
261 Li Y, McGrail DJ, Latysheva N, Yi S, Babu MM, Sahni N. Pathway perturbations in signaling networks: Linking genotype to phenotype. Semin Cell Dev Biol 2020;99:3-11. [PMID: 29738884 DOI: 10.1016/j.semcdb.2018.05.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
262 Moore KA, Pytowski B, Witte L, Hicklin D, Lemischka IR. Hematopoietic activity of a stromal cell transmembrane protein containing epidermal growth factor-like repeat motifs. Proc Natl Acad Sci U S A 1997;94:4011-6. [PMID: 9108096 DOI: 10.1073/pnas.94.8.4011] [Cited by in Crossref: 157] [Cited by in F6Publishing: 151] [Article Influence: 6.3] [Reference Citation Analysis]
263 Plaisance S, Vanden Berghe W, Boone E, Fiers W, Haegeman G. Recombination signal sequence binding protein Jkappa is constitutively bound to the NF-kappaB site of the interleukin-6 promoter and acts as a negative regulatory factor. Mol Cell Biol 1997;17:3733-43. [PMID: 9199307 DOI: 10.1128/MCB.17.7.3733] [Cited by in Crossref: 118] [Cited by in F6Publishing: 52] [Article Influence: 4.7] [Reference Citation Analysis]
264 Zhong R, Bao R, Faber PW, Bindokas VP, Bechill J, Lingen MW, Spiotto MT. Notch1 Activation or Loss Promotes HPV-Induced Oral Tumorigenesis. Cancer Res 2015;75:3958-69. [PMID: 26294213 DOI: 10.1158/0008-5472.CAN-15-0199] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
265 Ferrando AA. The role of NOTCH1 signaling in T-ALL. Hematology Am Soc Hematol Educ Program 2009;:353-61. [PMID: 20008221 DOI: 10.1182/asheducation-2009.1.353] [Cited by in Crossref: 119] [Cited by in F6Publishing: 118] [Article Influence: 9.9] [Reference Citation Analysis]
266 Briot A, Bouloumié A, Iruela-Arispe ML. Notch, lipids, and endothelial cells. Curr Opin Lipidol 2016;27:513-20. [PMID: 27454451 DOI: 10.1097/MOL.0000000000000337] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
267 Rots NY, Liu M, Anderson EC, Freedman LP. A differential screen for ligand-regulated genes: identification of HoxA10 as a target of vitamin D3 induction in myeloid leukemic cells. Mol Cell Biol 1998;18:1911-8. [PMID: 9528762 DOI: 10.1128/MCB.18.4.1911] [Cited by in Crossref: 66] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
268 Nakayama K, Nagase H, Koh CS, Ohkawara T. γ-Secretase-regulated mechanisms similar to notch signaling may play a role in signaling events, including APP signaling, which leads to Alzheimer's disease. Cell Mol Neurobiol 2011;31:887-900. [PMID: 21516353 DOI: 10.1007/s10571-011-9688-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
269 Minoguchi S, Taniguchi Y, Kato H, Okazaki T, Strobl LJ, Zimber-Strobl U, Bornkamm GW, Honjo T. RBP-L, a transcription factor related to RBP-Jkappa. Mol Cell Biol 1997;17:2679-87. [PMID: 9111338 DOI: 10.1128/MCB.17.5.2679] [Cited by in Crossref: 95] [Cited by in F6Publishing: 58] [Article Influence: 3.8] [Reference Citation Analysis]
270 Marchesini M, Gherli A, Montanaro A, Patrizi L, Sorrentino C, Pagliaro L, Rompietti C, Kitara S, Heit S, Olesen CE, Møller JV, Savi M, Bocchi L, Vilella R, Rizzi F, Baglione M, Rastelli G, Loiacono C, La Starza R, Mecucci C, Stegmaier K, Aversa F, Stilli D, Lund Winther AM, Sportoletti P, Bublitz M, Dalby-Brown W, Roti G. Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia. Cell Chem Biol 2020;27:678-697.e13. [PMID: 32386594 DOI: 10.1016/j.chembiol.2020.04.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
271 Sanders PG, Muñoz-Descalzo S, Balayo T, Wirtz-Peitz F, Hayward P, Arias AM. Ligand-independent traffic of Notch buffers activated Armadillo in Drosophila. PLoS Biol 2009;7:e1000169. [PMID: 19668359 DOI: 10.1371/journal.pbio.1000169] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 3.3] [Reference Citation Analysis]
272 Liu H, Chiang MY, Pear WS. Critical roles of NOTCH1 in acute T-cell lymphoblastic leukemia. Int J Hematol 2011;94:118-25. [PMID: 21814881 DOI: 10.1007/s12185-011-0899-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
273 Bugeon L, Taylor HB, Progatzky F, Lin MI, Ellis CD, Welsh N, Smith E, Vargesson N, Gray C, Renshaw SA, Chico TJ, Zon LI, Lamb J, Dallman MJ. The NOTCH pathway contributes to cell fate decision in myelopoiesis. Haematologica 2011;96:1753-60. [PMID: 21933862 DOI: 10.3324/haematol.2011.044115] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
274 Steinbuck MP, Arakcheeva K, Winandy S. Novel TCR-Mediated Mechanisms of Notch Activation and Signaling. J Immunol 2018;200:997-1007. [PMID: 29288204 DOI: 10.4049/jimmunol.1700070] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
275 Li D, Masiero M, Banham AH, Harris AL. The notch ligand JAGGED1 as a target for anti-tumor therapy. Front Oncol 2014;4:254. [PMID: 25309874 DOI: 10.3389/fonc.2014.00254] [Cited by in Crossref: 98] [Cited by in F6Publishing: 94] [Article Influence: 12.3] [Reference Citation Analysis]
276 Groth C, Fortini ME. Therapeutic approaches to modulating Notch signaling: current challenges and future prospects. Semin Cell Dev Biol 2012;23:465-72. [PMID: 22309842 DOI: 10.1016/j.semcdb.2012.01.016] [Cited by in Crossref: 86] [Cited by in F6Publishing: 79] [Article Influence: 8.6] [Reference Citation Analysis]
277 Ross DA, Kadesch T. The notch intracellular domain can function as a coactivator for LEF-1. Mol Cell Biol 2001;21:7537-44. [PMID: 11604490 DOI: 10.1128/MCB.21.22.7537-7544.2001] [Cited by in Crossref: 79] [Cited by in F6Publishing: 47] [Article Influence: 3.8] [Reference Citation Analysis]
278 Bao ZZ, Cepko CL. The expression and function of Notch pathway genes in the developing rat eye. J Neurosci 1997;17:1425-34. [PMID: 9006984 [PMID: 9006984 DOI: 10.1523/jneurosci.17-04-01425.1997] [Cited by in Crossref: 216] [Article Influence: 8.6] [Reference Citation Analysis]
279 Henderson LJ, Coe BP, Lee EH, Girard L, Gazdar AF, Minna JD, Lam S, MacAulay C, Lam WL. Genomic and gene expression profiling of minute alterations of chromosome arm 1p in small-cell lung carcinoma cells. Br J Cancer 2005;92:1553-60. [PMID: 15785753 DOI: 10.1038/sj.bjc.6602452] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
280 Tyagi A, Sharma AK, Damodaran C. A Review on Notch Signaling and Colorectal Cancer. Cells 2020;9:E1549. [PMID: 32630477 DOI: 10.3390/cells9061549] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
281 Misiorek JO, Przybyszewska-Podstawka A, Kałafut J, Paziewska B, Rolle K, Rivero-Müller A, Nees M. Context Matters: NOTCH Signatures and Pathway in Cancer Progression and Metastasis. Cells 2021;10:E94. [PMID: 33430387 DOI: 10.3390/cells10010094] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
282 Strobl LJ, Höfelmayr H, Marschall G, Brielmeier M, Bornkamm GW, Zimber-Strobl U. Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2. J Virol 2000;74:1727-35. [PMID: 10644343 DOI: 10.1128/jvi.74.4.1727-1735.2000] [Cited by in Crossref: 66] [Cited by in F6Publishing: 37] [Article Influence: 3.0] [Reference Citation Analysis]
283 Miyamoto S, Nakanishi M, Rosenberg DW. Suppression of colon carcinogenesis by targeting Notch signaling. Carcinogenesis. 2013;34:2415-2423. [PMID: 23729655 DOI: 10.1093/carcin/bgt191] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
284 Majumder S, Crabtree JS, Golde TE, Minter LM, Osborne BA, Miele L. Targeting Notch in oncology: the path forward. Nat Rev Drug Discov 2021;20:125-44. [PMID: 33293690 DOI: 10.1038/s41573-020-00091-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 6.5] [Reference Citation Analysis]
285 Khwaja SS, Liu H, Tong C, Jin F, Pear WS, van Deursen J, Bram RJ. HIV-1 Rev-binding protein accelerates cellular uptake of iron to drive Notch-induced T cell leukemogenesis in mice. J Clin Invest 2010;120:2537-48. [PMID: 20516639 DOI: 10.1172/JCI41277] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
286 Joshi I, Minter LM, Telfer J, Demarest RM, Capobianco AJ, Aster JC, Sicinski P, Fauq A, Golde TE, Osborne BA. Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases. Blood. 2009;113:1689-1698. [PMID: 19001083 DOI: 10.1182/blood-2008-03-147967] [Cited by in Crossref: 126] [Cited by in F6Publishing: 121] [Article Influence: 9.0] [Reference Citation Analysis]
287 Shen Y, Park CS, Suppipat K, Mistretta TA, Puppi M, Horton TM, Rabin K, Gray NS, Meijerink JPP, Lacorazza HD. Inactivation of KLF4 promotes T-cell acute lymphoblastic leukemia and activates the MAP2K7 pathway. Leukemia 2017;31:1314-24. [PMID: 27872496 DOI: 10.1038/leu.2016.339] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
288 Brown P, Hunger SP, Smith FO, Carroll WL, Reaman GH. Novel targeted drug therapies for the treatment of childhood acute leukemia. Expert Rev Hematol 2009;2:145. [PMID: 20126514 DOI: 10.1586/ehm.09.1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
289 Sanalkumar R, Dhanesh SB, James J. Non-canonical activation of Notch signaling/target genes in vertebrates. Cell Mol Life Sci 2010;67:2957-68. [PMID: 20458516 DOI: 10.1007/s00018-010-0391-x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 5.5] [Reference Citation Analysis]
290 Zong ZH, Liu Y, Chen S, Zhao Y. Circ_PUM1 promotes the development of endometrial cancer by targeting the miR-136/NOTCH3 pathway. J Cell Mol Med 2020;24:4127-35. [PMID: 32073729 DOI: 10.1111/jcmm.15069] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 12.0] [Reference Citation Analysis]
291 Groot AJ, Vooijs MA. The role of Adams in Notch signaling. Adv Exp Med Biol 2012;727:15-36. [PMID: 22399336 DOI: 10.1007/978-1-4614-0899-4_2] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 4.2] [Reference Citation Analysis]
292 Chiaretti S, Gianfelici V, Ceglie G, Foà R. Genomic characterization of acute leukemias. Med Princ Pract 2014;23:487-506. [PMID: 24968698 DOI: 10.1159/000362793] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
293 Guan E, Wang J, Laborda J, Norcross M, Baeuerle PA, Hoffman T. T cell leukemia-associated human Notch/translocation-associated Notch homologue has I kappa B-like activity and physically interacts with nuclear factor-kappa B proteins in T cells. J Exp Med 1996;183:2025-32. [PMID: 8642313 DOI: 10.1084/jem.183.5.2025] [Cited by in Crossref: 104] [Cited by in F6Publishing: 100] [Article Influence: 4.0] [Reference Citation Analysis]
294 Weber JM, Calvi LM. Notch signaling and the bone marrow hematopoietic stem cell niche. Bone 2010;46:281-5. [PMID: 19679213 DOI: 10.1016/j.bone.2009.08.007] [Cited by in Crossref: 74] [Cited by in F6Publishing: 69] [Article Influence: 5.7] [Reference Citation Analysis]
295 Ferrante AW Jr, Reinke R, Stanley ER. Shark, a Src homology 2, ankyrin repeat, tyrosine kinase, is expressed on the apical surfaces of ectodermal epithelia. Proc Natl Acad Sci U S A 1995;92:1911-5. [PMID: 7892198 DOI: 10.1073/pnas.92.6.1911] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 0.7] [Reference Citation Analysis]
296 Bertrand FE, Angus CW, Partis WJ, Sigounas G. Developmental pathways in colon cancer: crosstalk between WNT, BMP, Hedgehog and Notch. Cell Cycle 2012;11:4344-51. [PMID: 23032367 DOI: 10.4161/cc.22134] [Cited by in Crossref: 107] [Cited by in F6Publishing: 96] [Article Influence: 10.7] [Reference Citation Analysis]
297 Lavaissiere L, Jia S, Nishiyama M, de la Monte S, Stern AM, Wands JR, Friedman PA. Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma. J Clin Invest 1996;98:1313-23. [PMID: 8823296 DOI: 10.1172/JCI118918] [Cited by in Crossref: 90] [Cited by in F6Publishing: 56] [Article Influence: 3.5] [Reference Citation Analysis]
298 Espinoza I, Miele L. Notch inhibitors for cancer treatment. Pharmacol Ther 2013;139:95-110. [PMID: 23458608 DOI: 10.1016/j.pharmthera.2013.02.003] [Cited by in Crossref: 178] [Cited by in F6Publishing: 167] [Article Influence: 19.8] [Reference Citation Analysis]
299 Michmerhuizen NL, Birkeland AC, Bradford CR, Brenner JC. Genetic determinants in head and neck squamous cell carcinoma and their influence on global personalized medicine. Genes Cancer 2016;7:182-200. [PMID: 27551333 DOI: 10.18632/genesandcancer.110] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
300 Mrózek K, Harper DP, Aplan PD. Cytogenetics and molecular genetics of acute lymphoblastic leukemia. Hematol Oncol Clin North Am 2009;23:991-1010, v. [PMID: 19825449 DOI: 10.1016/j.hoc.2009.07.001] [Cited by in Crossref: 75] [Cited by in F6Publishing: 58] [Article Influence: 6.3] [Reference Citation Analysis]
301 Chen H, Thiagalingam A, Chopra H, Borges MW, Feder JN, Nelkin BD, Baylin SB, Ball DW. Conservation of the Drosophila lateral inhibition pathway in human lung cancer: a hairy-related protein (HES-1) directly represses achaete-scute homolog-1 expression. Proc Natl Acad Sci U S A 1997;94:5355-60. [PMID: 9144241 DOI: 10.1073/pnas.94.10.5355] [Cited by in Crossref: 198] [Cited by in F6Publishing: 202] [Article Influence: 7.9] [Reference Citation Analysis]
302 Kim R, Trubetskoy A, Suzuki T, Jenkins NA, Copeland NG, Lenz J. Genome-based identification of cancer genes by proviral tagging in mouse retrovirus-induced T-cell lymphomas. J Virol 2003;77:2056-62. [PMID: 12525640 DOI: 10.1128/jvi.77.3.2056-2062.2003] [Cited by in Crossref: 76] [Cited by in F6Publishing: 44] [Article Influence: 4.0] [Reference Citation Analysis]
303 Veeraraghavalu K, Pett M, Kumar RV, Nair P, Rangarajan A, Stanley MA, Krishna S. Papillomavirus-mediated neoplastic progression is associated with reciprocal changes in JAGGED1 and manic fringe expression linked to notch activation. J Virol 2004;78:8687-700. [PMID: 15280477 DOI: 10.1128/JVI.78.16.8687-8700.2004] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
304 Cooper A, Johannsen E, Maruo S, Cahir-McFarland E, Illanes D, Davidson D, Kieff E. EBNA3A association with RBP-Jkappa down-regulates c-myc and Epstein-Barr virus-transformed lymphoblast growth. J Virol 2003;77:999-1010. [PMID: 12502816 DOI: 10.1128/jvi.77.2.999-1010.2003] [Cited by in Crossref: 49] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
305 Groot AJ, Habets R, Yahyanejad S, Hodin CM, Reiss K, Saftig P, Theys J, Vooijs M. Regulated proteolysis of NOTCH2 and NOTCH3 receptors by ADAM10 and presenilins. Mol Cell Biol 2014;34:2822-32. [PMID: 24842903 DOI: 10.1128/MCB.00206-14] [Cited by in Crossref: 55] [Cited by in F6Publishing: 40] [Article Influence: 6.9] [Reference Citation Analysis]
306 Pakkiriswami S, Couto A, Nagarajan U, Georgiou M. Glycosylated Notch and Cancer. Front Oncol. 2016;6:37. [PMID: 26925390 DOI: 10.3389/fonc.2016.00037] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
307 Lim KJ, Brandt WD, Heth JA, Muraszko KM, Fan X, Bar EE, Eberhart CG. Lateral inhibition of Notch signaling in neoplastic cells. Oncotarget 2015;6:1666-77. [PMID: 25557173 DOI: 10.18632/oncotarget.2762] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
308 Phelan JD, Saba I, Zeng H, Kosan C, Messer MS, Olsson HA, Fraszczak J, Hildeman DA, Aronow BJ, Möröy T, Grimes HL. Growth factor independent-1 maintains Notch1-dependent transcriptional programming of lymphoid precursors. PLoS Genet 2013;9:e1003713. [PMID: 24068942 DOI: 10.1371/journal.pgen.1003713] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
309 Gordon WR, Roy M, Vardar-Ulu D, Garfinkel M, Mansour MR, Aster JC, Blacklow SC. Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALL. Blood 2009;113:4381-90. [PMID: 19075186 DOI: 10.1182/blood-2008-08-174748] [Cited by in Crossref: 115] [Cited by in F6Publishing: 107] [Article Influence: 8.2] [Reference Citation Analysis]
310 Choi K, Ahn YH, Gibbons DL, Tran HT, Creighton CJ, Girard L, Minna JD, Qin FX, Kurie JM. Distinct biological roles for the notch ligands Jagged-1 and Jagged-2. J Biol Chem 2009;284:17766-74. [PMID: 19398556 DOI: 10.1074/jbc.M109.003111] [Cited by in Crossref: 39] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
311 Ranganathan P, Weaver KL, Capobianco AJ. Notch signalling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer. 2011;11:338-351. [PMID: 21508972 DOI: 10.1038/nrc3035] [Cited by in Crossref: 523] [Cited by in F6Publishing: 496] [Article Influence: 47.5] [Reference Citation Analysis]
312 Johansson E, Rönö B, Johansson M, Lindgren D, Möller C, Axelson H, Smith EM. Simultaneous targeted activation of Notch1 and Vhl-disruption in the kidney proximal epithelial tubular cells in mice. Sci Rep 2016;6:30739. [PMID: 27491826 DOI: 10.1038/srep30739] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
313 Jeffries S, Capobianco AJ. Neoplastic transformation by Notch requires nuclear localization. Mol Cell Biol. 2000;20:3928-3941. [PMID: 10805736 DOI: 10.1128/mcb.20.11.3928-3941.2000] [Cited by in Crossref: 90] [Cited by in F6Publishing: 40] [Article Influence: 4.1] [Reference Citation Analysis]
314 Brimer N, Lyons C, Wallberg AE, Vande Pol SB. Cutaneous papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and NOTCH signaling. Oncogene 2012;31:4639-46. [PMID: 22249263 DOI: 10.1038/onc.2011.589] [Cited by in Crossref: 89] [Cited by in F6Publishing: 81] [Article Influence: 8.9] [Reference Citation Analysis]
315 Wang Z, Wu J, Tian X, Hao C. Targeted therapy of desmoid-type fibromatosis: mechanism, current situation, and future prospects. Front Med 2019;13:427-37. [PMID: 30798508 DOI: 10.1007/s11684-018-0672-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
316 Fre S, Pallavi SK, Huyghe M, Laé M, Janssen KP, Robine S, Artavanis-Tsakonas S, Louvard D. Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine. Proc Natl Acad Sci U S A 2009;106:6309-14. [PMID: 19251639 DOI: 10.1073/pnas.0900427106] [Cited by in Crossref: 227] [Cited by in F6Publishing: 212] [Article Influence: 17.5] [Reference Citation Analysis]
317 Deng G, Ma L, Meng Q, Ju X, Jiang K, Jiang P, Yu Z. Notch signaling in the prostate: critical roles during development and in the hallmarks of prostate cancer biology. J Cancer Res Clin Oncol 2016;142:531-47. [PMID: 25736982 DOI: 10.1007/s00432-015-1946-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
318 McGregor S, McNeer J, Gurbuxani S. Beyond the 2008 World Health Organization classification: the role of the hematopathology laboratory in the diagnosis and management of acute lymphoblastic leukemia. Semin Diagn Pathol 2012;29:2-11. [PMID: 22372201 DOI: 10.1053/j.semdp.2011.07.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
319 Tosello V, Mansour MR, Barnes K, Paganin M, Sulis ML, Jenkinson S, Allen CG, Gale RE, Linch DC, Palomero T, Real P, Murty V, Yao X, Richards SM, Goldstone A, Rowe J, Basso G, Wiernik PH, Paietta E, Pieters R, Horstmann M, Meijerink JP, Ferrando AA. WT1 mutations in T-ALL. Blood 2009;114:1038-45. [PMID: 19494353 DOI: 10.1182/blood-2008-12-192039] [Cited by in Crossref: 88] [Cited by in F6Publishing: 81] [Article Influence: 6.8] [Reference Citation Analysis]
320 Huang Q, Raya A, DeJesus P, Chao SH, Quon KC, Caldwell JS, Chanda SK, Izpisua-Belmonte JC, Schultz PG. Identification of p53 regulators by genome-wide functional analysis. Proc Natl Acad Sci U S A 2004;101:3456-61. [PMID: 14990790 DOI: 10.1073/pnas.0308562100] [Cited by in Crossref: 110] [Cited by in F6Publishing: 110] [Article Influence: 6.1] [Reference Citation Analysis]
321 Yanagawa S, Lee JS, Kakimi K, Matsuda Y, Honjo T, Ishimoto A. Identification of Notch1 as a frequent target for provirus insertional mutagenesis in T-cell lymphomas induced by leukemogenic mutants of mouse mammary tumor virus. J Virol 2000;74:9786-91. [PMID: 11000255 DOI: 10.1128/jvi.74.20.9786-9791.2000] [Cited by in Crossref: 29] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
322 Jarriault S, Le Bail O, Hirsinger E, Pourquié O, Logeat F, Strong CF, Brou C, Seidah NG, Isra l A. Delta-1 activation of notch-1 signaling results in HES-1 transactivation. Mol Cell Biol 1998;18:7423-31. [PMID: 9819428 DOI: 10.1128/MCB.18.12.7423] [Cited by in Crossref: 250] [Cited by in F6Publishing: 108] [Article Influence: 10.4] [Reference Citation Analysis]
323 Cook GJ, Pardee TS. Animal models of leukemia: any closer to the real thing? Cancer Metastasis Rev 2013;32:63-76. [PMID: 23081702 DOI: 10.1007/s10555-012-9405-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
324 Aster JC, Xu L, Karnell FG, Patriub V, Pui JC, Pear WS. Essential roles for ankyrin repeat and transactivation domains in induction of T-cell leukemia by notch1. Mol Cell Biol 2000;20:7505-15. [PMID: 11003647 DOI: 10.1128/MCB.20.20.7505-7515.2000] [Cited by in Crossref: 207] [Cited by in F6Publishing: 109] [Article Influence: 9.4] [Reference Citation Analysis]
325 Pradeep CR, Köstler WJ, Lauriola M, Granit RZ, Zhang F, Jacob-Hirsch J, Rechavi G, Nair HB, Hennessy BT, Gonzalez-Angulo AM, Tekmal RR, Ben-Porath I, Mills GB, Domany E, Yarden Y. Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal filling. Oncogene 2012;31:907-17. [PMID: 21743488 DOI: 10.1038/onc.2011.279] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
326 Talora C, Campese AF, Bellavia D, Pascucci M, Checquolo S, Groppioni M, Frati L, von Boehmer H, Gulino A, Screpanti I. Pre-TCR-triggered ERK signalling-dependent downregulation of E2A activity in Notch3-induced T-cell lymphoma. EMBO Rep 2003;4:1067-72. [PMID: 14566327 DOI: 10.1038/sj.embor.embor7400013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 23] [Article Influence: 0.1] [Reference Citation Analysis]
327 Robertson ES, Lin J, Kieff E. The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa). J Virol 1996;70:3068-74. [PMID: 8627785 DOI: 10.1128/JVI.70.5.3068-3074.1996] [Cited by in Crossref: 136] [Cited by in F6Publishing: 86] [Article Influence: 5.2] [Reference Citation Analysis]
328 O'Neil J, Grim J, Strack P, Rao S, Tibbitts D, Winter C, Hardwick J, Welcker M, Meijerink JP, Pieters R, Draetta G, Sears R, Clurman BE, Look AT. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J Exp Med 2007;204:1813-24. [PMID: 17646409 DOI: 10.1084/jem.20070876] [Cited by in Crossref: 462] [Cited by in F6Publishing: 447] [Article Influence: 30.8] [Reference Citation Analysis]
329 Chen Y, Zheng S, Qi D, Zheng S, Guo J, Zhang S, Weng Z. Inhibition of Notch signaling by a γ-secretase inhibitor attenuates hepatic fibrosis in rats. PLoS One. 2012;7:e46512. [PMID: 23056328 DOI: 10.1371/journal.pone.0046512] [Cited by in Crossref: 78] [Cited by in F6Publishing: 93] [Article Influence: 7.8] [Reference Citation Analysis]
330 Hernandez Tejada FN. Galvez Silva JR, Zweidler-McKay PA. The challenge of targeting notch in hematologic malignancies. Front Pediatr. 2014;2:54. [PMID: 24959528 DOI: 10.3389/fped.2014.00054] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
331 Schroeder T, Fraser ST, Ogawa M, Nishikawa S, Oka C, Bornkamm GW, Nishikawa S, Honjo T, Just U. Recombination signal sequence-binding protein Jkappa alters mesodermal cell fate decisions by suppressing cardiomyogenesis. Proc Natl Acad Sci U S A 2003;100:4018-23. [PMID: 12655061 DOI: 10.1073/pnas.0438008100] [Cited by in Crossref: 100] [Cited by in F6Publishing: 96] [Article Influence: 5.3] [Reference Citation Analysis]
332 Palomero T, Ferrando A. Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemia. Clin Lymphoma Myeloma 2009;9 Suppl 3:S205-10. [PMID: 19778842 DOI: 10.3816/CLM.2009.s.013] [Cited by in Crossref: 47] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
333 Wang Z, Li Y, Sarkar FH. Notch signaling proteins: legitimate targets for cancer therapy. Curr Protein Pept Sci 2010;11:398-408. [PMID: 20491628 DOI: 10.2174/138920310791824039] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
334 Paganin M, Ferrando A. Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia. Blood Rev 2011;25:83-90. [PMID: 20965628 DOI: 10.1016/j.blre.2010.09.004] [Cited by in Crossref: 105] [Cited by in F6Publishing: 98] [Article Influence: 8.8] [Reference Citation Analysis]
335 Baker AT, Zlobin A, Osipo C. Notch-EGFR/HER2 Bidirectional Crosstalk in Breast Cancer. Front Oncol 2014;4:360. [PMID: 25566499 DOI: 10.3389/fonc.2014.00360] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 5.3] [Reference Citation Analysis]
336 Strazzabosco M, Fabris L. Notch signaling in hepatocellular carcinoma: guilty in association! Gastroenterology. 2012;143:1430-1434. [PMID: 23099244 DOI: 10.1053/j.gastro.2012.10.025] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
337 Borah A, Raveendran S, Rochani A, Maekawa T, Kumar DS. Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy. Oncogenesis 2015;4:e177. [PMID: 26619402 DOI: 10.1038/oncsis.2015.35] [Cited by in Crossref: 95] [Cited by in F6Publishing: 92] [Article Influence: 13.6] [Reference Citation Analysis]
338 Oswald F, Liptay S, Adler G, Schmid RM. NF-kappaB2 is a putative target gene of activated Notch-1 via RBP-Jkappa. Mol Cell Biol 1998;18:2077-88. [PMID: 9528780 DOI: 10.1128/MCB.18.4.2077] [Cited by in Crossref: 200] [Cited by in F6Publishing: 86] [Article Influence: 8.3] [Reference Citation Analysis]
339 Yang Y, Ashwell JD. Thymocyte apoptosis. J Clin Immunol 1999;19:337-49. [PMID: 10634208 DOI: 10.1023/a:1020594531159] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
340 Telerman A, Amson R. The molecular programme of tumour reversion: the steps beyond malignant transformation. Nat Rev Cancer. 2009;9:206-216. [PMID: 19180095 DOI: 10.1038/nrc2589] [Cited by in Crossref: 110] [Cited by in F6Publishing: 102] [Article Influence: 8.5] [Reference Citation Analysis]
341 Nair P, Somasundaram K, Krishna S. Activated Notch1 inhibits p53-induced apoptosis and sustains transformation by human papillomavirus type 16 E6 and E7 oncogenes through a PI3K-PKB/Akt-dependent pathway. J Virol 2003;77:7106-12. [PMID: 12768030 DOI: 10.1128/jvi.77.12.7106-7112.2003] [Cited by in Crossref: 126] [Cited by in F6Publishing: 61] [Article Influence: 6.6] [Reference Citation Analysis]
342 Tungmunnithum D, Thongboonyou A, Pholboon A, Yangsabai A. Flavonoids and Other Phenolic Compounds from Medicinal Plants for Pharmaceutical and Medical Aspects: An Overview. Medicines (Basel) 2018;5:E93. [PMID: 30149600 DOI: 10.3390/medicines5030093] [Cited by in Crossref: 258] [Cited by in F6Publishing: 169] [Article Influence: 64.5] [Reference Citation Analysis]
343 Xiao X, Ning L, Chen H. Notch1 mediates growth suppression of papillary and follicular thyroid cancer cells by histone deacetylase inhibitors. Mol Cancer Ther. 2009;8:350-356. [PMID: 19190121 DOI: 10.1158/1535-7163.mct-08-0585] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
344 Huang T, Zhou Y, Cheng AS, Yu J, To KF, Kang W. NOTCH receptors in gastric and other gastrointestinal cancers: oncogenes or tumor suppressors? Mol Cancer 2016;15:80. [PMID: 27938406 DOI: 10.1186/s12943-016-0566-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
345 de Celis JF, Barrio R, del Arco A, García-Bellido A. Genetic and molecular characterization of a Notch mutation in its Delta- and Serrate-binding domain in Drosophila. Proc Natl Acad Sci U S A 1993;90:4037-41. [PMID: 8483919 DOI: 10.1073/pnas.90.9.4037] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 1.9] [Reference Citation Analysis]
346 Mavrakis KJ, Wolfe AL, Oricchio E, Palomero T, de Keersmaecker K, McJunkin K, Zuber J, James T, Khan AA, Leslie CS. Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia. Nat Cell Biol. 2010;12:372-379. [PMID: 20190740 DOI: 10.1038/ncb2037] [Cited by in Crossref: 230] [Cited by in F6Publishing: 235] [Article Influence: 19.2] [Reference Citation Analysis]
347 Husain J, Lo R, Grbavec D, Stifani S. Affinity for the nuclear compartment and expression during cell differentiation implicate phosphorylated Groucho/TLE1 forms of higher molecular mass in nuclear functions. Biochem J 1996;317 ( Pt 2):523-31. [PMID: 8713081 DOI: 10.1042/bj3170523] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 1.5] [Reference Citation Analysis]
348 Palmieri G, Capone M, Ascierto ML, Gentilcore G, Stroncek DF, Casula M, Sini MC, Palla M, Mozzillo N, Ascierto PA. Main roads to melanoma. J Transl Med 2009;7:86. [PMID: 19828018 DOI: 10.1186/1479-5876-7-86] [Cited by in Crossref: 116] [Cited by in F6Publishing: 107] [Article Influence: 8.9] [Reference Citation Analysis]
349 Kuo MT. Redox regulation of multidrug resistance in cancer chemotherapy: molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal 2009;11:99-133. [PMID: 18699730 DOI: 10.1089/ars.2008.2095] [Cited by in Crossref: 87] [Cited by in F6Publishing: 79] [Article Influence: 6.2] [Reference Citation Analysis]
350 Nwaeburu CC, Abukiwan A, Zhao Z, Herr I. Quercetin-induced miR-200b-3p regulates the mode of self-renewing divisions in pancreatic cancer. Mol Cancer 2017;16:23. [PMID: 28137273 DOI: 10.1186/s12943-017-0589-8] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 9.6] [Reference Citation Analysis]
351 Prieto-Torres L, Rodriguez-Pinilla SM, Onaindia A, Ara M, Requena L, Piris MÁ. CD30-positive primary cutaneous lymphoproliferative disorders: molecular alterations and targeted therapies. Haematologica 2019;104:226-35. [PMID: 30630983 DOI: 10.3324/haematol.2018.197152] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
352 Capobianco AJ, Zagouras P, Blaumueller CM, Artavanis-Tsakonas S, Bishop JM. Neoplastic transformation by truncated alleles of human NOTCH1/TAN1 and NOTCH2. Mol Cell Biol 1997;17:6265-73. [PMID: 9343387 DOI: 10.1128/MCB.17.11.6265] [Cited by in Crossref: 183] [Cited by in F6Publishing: 66] [Article Influence: 7.3] [Reference Citation Analysis]
353 Zhu SS, Li WG. Advances in research of signaling pathways in cholangiocarcinoma. Shijie Huaren Xiaohua Zazhi 2012; 20(30): 2913-2919 [DOI: 10.11569/wcjd.v20.i30.2913] [Reference Citation Analysis]
354 Lee L, Fielding AK. Emerging pharmacotherapies for adult patients with acute lymphoblastic leukemia. Clin Med Insights Oncol 2012;6:85-100. [PMID: 22346368 DOI: 10.4137/CMO.S7262] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
355 Yu XM, Jaskula-Sztul R, Ahmed K, Harrison AD, Kunnimalaiyaan M, Chen H. Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth. Mol Cancer Ther 2013;12:1276-87. [PMID: 23594881 DOI: 10.1158/1535-7163.MCT-12-0841] [Cited by in Crossref: 57] [Cited by in F6Publishing: 41] [Article Influence: 6.3] [Reference Citation Analysis]
356 Palomero T, Ferrando A. Oncogenic NOTCH1 control of MYC and PI3K: challenges and opportunities for anti-NOTCH1 therapy in T-cell acute lymphoblastic leukemias and lymphomas. Clin Cancer Res 2008;14:5314-7. [PMID: 18765521 DOI: 10.1158/1078-0432.CCR-07-4864] [Cited by in Crossref: 57] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
357 Chang WH, Lai AG. Aberrations in Notch-Hedgehog signalling reveal cancer stem cells harbouring conserved oncogenic properties associated with hypoxia and immunoevasion. Br J Cancer 2019;121:666-78. [PMID: 31523055 DOI: 10.1038/s41416-019-0572-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
358 Rettig EM, Chung CH, Bishop JA, Howard JD, Sharma R, Li RJ, Douville C, Karchin R, Izumchenko E, Sidransky D, Koch W, Califano J, Agrawal N, Fakhry C. Cleaved NOTCH1 Expression Pattern in Head and Neck Squamous Cell Carcinoma Is Associated with NOTCH1 Mutation, HPV Status, and High-Risk Features. Cancer Prev Res (Phila) 2015;8:287-95. [PMID: 25633867 DOI: 10.1158/1940-6207.CAPR-14-0366] [Cited by in Crossref: 33] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
359 Contreras-Cornejo H, Saucedo-Correa G, Oviedo-Boyso J, Valdez-Alarcón JJ, Baizabal-Aguirre VM, Cajero-Juárez M, Bravo-Patiño A. The CSL proteins, versatile transcription factors and context dependent corepressors of the notch signaling pathway. Cell Div 2016;11:12. [PMID: 27708688 DOI: 10.1186/s13008-016-0025-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
360 Mukherjee S, Tucker-Burden C, Zhang C, Moberg K, Read R, Hadjipanayis C, Brat DJ. Drosophila Brat and Human Ortholog TRIM3 Maintain Stem Cell Equilibrium and Suppress Brain Tumorigenesis by Attenuating Notch Nuclear Transport. Cancer Res 2016;76:2443-52. [PMID: 26893479 DOI: 10.1158/0008-5472.CAN-15-2299] [Cited by in Crossref: 32] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
361 Habets RA, Groot AJ, Yahyanejad S, Tiyanont K, Blacklow SC, Vooijs M. Human NOTCH2 Is Resistant to Ligand-independent Activation by Metalloprotease Adam17. J Biol Chem 2015;290:14705-16. [PMID: 25918160 DOI: 10.1074/jbc.M115.643676] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
362 Lobry C, Oh P, Aifantis I. Oncogenic and tumor suppressor functions of Notch in cancer: it’s NOTCH what you think. J Exp Med. 2011;208:1931-1935. [PMID: 21948802 DOI: 10.1084/jem.20111855] [Cited by in Crossref: 238] [Cited by in F6Publishing: 240] [Article Influence: 21.6] [Reference Citation Analysis]
363 Song HY, Wang Y, Lan H, Zhang YX. Expression of Notch receptors and their ligands in pancreatic ductal adenocarcinoma. Exp Ther Med 2018;16:53-60. [PMID: 29896227 DOI: 10.3892/etm.2018.6172] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
364 Johnson SE, Barrick D. Dissecting and circumventing the requirement for RAM in CSL-dependent Notch signaling. PLoS One 2012;7:e39093. [PMID: 22876274 DOI: 10.1371/journal.pone.0039093] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
365 Lubman OY, Ilagan MX, Kopan R, Barrick D. Quantitative dissection of the Notch:CSL interaction: insights into the Notch-mediated transcriptional switch. J Mol Biol 2007;365:577-89. [PMID: 17070841 DOI: 10.1016/j.jmb.2006.09.071] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 4.3] [Reference Citation Analysis]
366 Parmigiani E, Taylor V, Giachino C. Oncogenic and Tumor-Suppressive Functions of NOTCH Signaling in Glioma. Cells 2020;9:E2304. [PMID: 33076453 DOI: 10.3390/cells9102304] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
367 Sjölund J, Johansson M, Manna S, Norin C, Pietras A, Beckman S, Nilsson E, Ljungberg B, Axelson H. Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo. J Clin Invest 2008;118:217-28. [PMID: 18079963 DOI: 10.1172/JCI32086] [Cited by in Crossref: 134] [Cited by in F6Publishing: 79] [Article Influence: 9.6] [Reference Citation Analysis]
368 Weng AP, Millholland JM, Yashiro-Ohtani Y, Arcangeli ML, Lau A, Wai C, Del Bianco C, Rodriguez CG, Sai H, Tobias J. c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. Genes Dev. 2006;20:2096-2109. [PMID: 16847353 DOI: 10.1101/gad.1450406] [Cited by in Crossref: 605] [Cited by in F6Publishing: 569] [Article Influence: 37.8] [Reference Citation Analysis]
369 Harada S, Yalamanchili R, Kieff E. Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation. J Virol 1998;72:9948-54. [PMID: 9811732 DOI: 10.1128/JVI.72.12.9948-9954.1998] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
370 Yu XM, Phan T, Patel PN, Jaskula-Sztul R, Chen H. Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivo. Cancer 2013;119:774-81. [PMID: 22991264 DOI: 10.1002/cncr.27742] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 5.7] [Reference Citation Analysis]
371 Jans DA. The regulation of protein transport to the nucleus by phosphorylation. Biochem J 1995;311 ( Pt 3):705-16. [PMID: 7487922 DOI: 10.1042/bj3110705] [Cited by in Crossref: 145] [Cited by in F6Publishing: 144] [Article Influence: 5.4] [Reference Citation Analysis]
372 Kimura S, Seki M, Yoshida K, Shiraishi Y, Akiyama M, Koh K, Imamura T, Manabe A, Hayashi Y, Kobayashi M, Oka A, Miyano S, Ogawa S, Takita J. NOTCH1 pathway activating mutations and clonal evolution in pediatric T-cell acute lymphoblastic leukemia. Cancer Sci 2019;110:784-94. [PMID: 30387229 DOI: 10.1111/cas.13859] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
373 Fattizzo B, Rosa J, Giannotta JA, Baldini L, Fracchiolla NS. The Physiopathology of T- Cell Acute Lymphoblastic Leukemia: Focus on Molecular Aspects. Front Oncol 2020;10:273. [PMID: 32185137 DOI: 10.3389/fonc.2020.00273] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
374 Lin YW, Nichols RA, Letterio JJ, Aplan PD. Notch1 mutations are important for leukemic transformation in murine models of precursor-T leukemia/lymphoma. Blood 2006;107:2540-3. [PMID: 16282337 DOI: 10.1182/blood-2005-07-3013] [Cited by in Crossref: 89] [Cited by in F6Publishing: 85] [Article Influence: 5.2] [Reference Citation Analysis]
375 Stoeck A, Lejnine S, Truong A, Pan L, Wang H, Zang C, Yuan J, Ware C, MacLean J, Garrett-Engele PW, Kluk M, Laskey J, Haines BB, Moskaluk C, Zawel L, Fawell S, Gilliland G, Zhang T, Kremer BE, Knoechel B, Bernstein BE, Pear WS, Liu XS, Aster JC, Sathyanarayanan S. Discovery of biomarkers predictive of GSI response in triple-negative breast cancer and adenoid cystic carcinoma. Cancer Discov 2014;4:1154-67. [PMID: 25104330 DOI: 10.1158/2159-8290.CD-13-0830] [Cited by in Crossref: 84] [Cited by in F6Publishing: 59] [Article Influence: 10.5] [Reference Citation Analysis]
376 Pallavi SK, Ho DM, Hicks C, Miele L, Artavanis-Tsakonas S. Notch and Mef2 synergize to promote proliferation and metastasis through JNK signal activation in Drosophila. EMBO J 2012;31:2895-907. [PMID: 22580825 DOI: 10.1038/emboj.2012.129] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 5.3] [Reference Citation Analysis]
377 Zhu F, Li T, Qiu F, Fan J, Zhou Q, Ding X, Nie J, Yu X. Preventive effect of Notch signaling inhibition by a gamma-secretase inhibitor on peritoneal dialysis fluid-induced peritoneal fibrosis in rats. Am J Pathol. 2010;176:650-659. [PMID: 20056840 DOI: 10.2353/ajpath.2010.090447] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
378 Kodoyianni V, Maine EM, Kimble J. Molecular basis of loss-of-function mutations in the glp-1 gene of Caenorhabditis elegans. Mol Biol Cell 1992;3:1199-213. [PMID: 1457827 DOI: 10.1091/mbc.3.11.1199] [Cited by in Crossref: 98] [Cited by in F6Publishing: 101] [Article Influence: 3.4] [Reference Citation Analysis]
379 Lyman D, Young MW. Further evidence for function of the Drosophila Notch protein as a transmembrane receptor. Proc Natl Acad Sci U S A 1993;90:10395-9. [PMID: 8234305 DOI: 10.1073/pnas.90.21.10395] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 1.4] [Reference Citation Analysis]
380 Redmond EM, Guha S, Walls D, Cahill PA. Investigational Notch and Hedgehog inhibitors--therapies for cardiovascular disease. Expert Opin Investig Drugs 2011;20:1649-64. [PMID: 22007748 DOI: 10.1517/13543784.2011.628658] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
381 Talora C, Campese AF, Bellavia D, Pascucci M, Checquolo S, Groppioni M, Frati L, von Boehmer H, Gulino A, Screpanti I. Pre-TCR-triggered ERK signalling-dependent downregulation of E2A activity in Notch3-induced T-cell lymphoma. EMBO Rep 2003;4:1067-72. [PMID: 14566327 DOI: 10.1038/sj.embor.embor7400013] [Cited by in Crossref: 56] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
382 Orzechowska M, Anusewicz D, Bednarek AK. Functional Gene Expression Differentiation of the Notch Signaling Pathway in Female Reproductive Tract Tissues-A Comprehensive Review With Analysis. Front Cell Dev Biol 2020;8:592616. [PMID: 33384996 DOI: 10.3389/fcell.2020.592616] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
383 Nefedova Y, Gabrilovich D. Mechanisms and clinical prospects of Notch inhibitors in the therapy of hematological malignancies. Drug Resist Updat 2008;11:210-8. [PMID: 18951834 DOI: 10.1016/j.drup.2008.09.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
384 Aster JC. Deregulated NOTCH signaling in acute T-cell lymphoblastic leukemia/lymphoma: new insights, questions, and opportunities. Int J Hematol 2005;82:295-301. [PMID: 16298817 DOI: 10.1532/IJH97.05096] [Cited by in Crossref: 30] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
385 Rad R, Rad L, Wang W, Cadinanos J, Vassiliou G, Rice S, Campos LS, Yusa K, Banerjee R, Li MA, de la Rosa J, Strong A, Lu D, Ellis P, Conte N, Yang FT, Liu P, Bradley A. PiggyBac transposon mutagenesis: a tool for cancer gene discovery in mice. Science 2010;330:1104-7. [PMID: 20947725 DOI: 10.1126/science.1193004] [Cited by in Crossref: 166] [Cited by in F6Publishing: 156] [Article Influence: 13.8] [Reference Citation Analysis]
386 Leong KG, Hu X, Li L, Noseda M, Larrivée B, Hull C, Hood L, Wong F, Karsan A. Activated Notch4 inhibits angiogenesis: role of beta 1-integrin activation. Mol Cell Biol 2002;22:2830-41. [PMID: 11909975 DOI: 10.1128/MCB.22.8.2830-2841.2002] [Cited by in Crossref: 122] [Cited by in F6Publishing: 53] [Article Influence: 6.1] [Reference Citation Analysis]
387 Valenti L, Mendoza RM, Rametta R, Maggioni M, Kitajewski C, Shawber CJ, Pajvani UB. Hepatic Notch Signalling Correlates with Insulin Resistance and Non-Alcoholic Fatty Liver Disease. Diabetes. 2013;62:4052-4062. [PMID: 23990360 DOI: 10.2337/db13-0769] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 6.0] [Reference Citation Analysis]
388 Xiong H, Maraver A, Latkowski JA, Henderson T, Schlessinger K, Ding Y, Shen J, Tadokoro CE, Lafaille JJ. Characterization of two distinct lymphoproliferative diseases caused by ectopic expression of the Notch ligand DLL4 on T cells. PLoS One 2013;8:e84841. [PMID: 24386421 DOI: 10.1371/journal.pone.0084841] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
389 Lindner V, Booth C, Prudovsky I, Small D, Maciag T, Liaw L. Members of the Jagged/Notch gene families are expressed in injured arteries and regulate cell phenotype via alterations in cell matrix and cell-cell interaction. Am J Pathol. 2001;159:875-883. [PMID: 11549580 DOI: 10.1016/s0002-9440(10)61763-4] [Cited by in Crossref: 129] [Cited by in F6Publishing: 51] [Article Influence: 6.1] [Reference Citation Analysis]
390 Rothenberg SM, Ellisen LW. The molecular pathogenesis of head and neck squamous cell carcinoma. J Clin Invest 2012;122:1951-7. [PMID: 22833868 DOI: 10.1172/jci59889] [Cited by in Crossref: 225] [Cited by in F6Publishing: 147] [Article Influence: 22.5] [Reference Citation Analysis]
391 Crabtree JS, Singleton CS, Miele L. Notch Signaling in Neuroendocrine Tumors. Front Oncol. 2016;6:94. [PMID: 27148486 DOI: 10.3389/fonc.2016.00094] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 5.7] [Reference Citation Analysis]
392 Hussain I, Fabrègue J, Anderes L, Ousson S, Borlat F, Eligert V, Berger S, Dimitrov M, Alattia JR, Fraering PC, Beher D. The role of γ-secretase activating protein (GSAP) and imatinib in the regulation of γ-secretase activity and amyloid-β generation. J Biol Chem 2013;288:2521-31. [PMID: 23209290 DOI: 10.1074/jbc.M112.370924] [Cited by in Crossref: 36] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
393 Dail M, Li Q, McDaniel A, Wong J, Akagi K, Huang B, Kang HC, Kogan SC, Shokat K, Wolff L, Braun BS, Shannon K. Mutant Ikzf1, KrasG12D, and Notch1 cooperate in T lineage leukemogenesis and modulate responses to targeted agents. Proc Natl Acad Sci U S A 2010;107:5106-11. [PMID: 20194733 DOI: 10.1073/pnas.1001064107] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 4.3] [Reference Citation Analysis]
394 Mansur MB, Hassan R, Barbosa TC, Splendore A, Jotta PY, Yunes JA, Wiemels JL, Pombo-de-Oliveira MS. Impact of complex NOTCH1 mutations on survival in paediatric T-cell leukaemia. BMC Cancer 2012;12:9. [PMID: 22225590 DOI: 10.1186/1471-2407-12-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
395 Lan K, Murakami M, Bajaj B, Kaul R, He Z, Gan R, Feldman M, Robertson ES. Inhibition of KSHV-infected primary effusion lymphomas in NOD/SCID mice by gamma-secretase inhibitor. Cancer Biol Ther 2009;8:2136-43. [PMID: 19783901 DOI: 10.4161/cbt.8.22.9743] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
396 Zhu Z, Todorova K, Lee KK, Wang J, Kwon E, Kehayov I, Kim HG, Kolev V, Dotto GP, Lee SW, Mandinova A. Small GTPase RhoE/Rnd3 is a critical regulator of Notch1 signaling. Cancer Res 2014;74:2082-93. [PMID: 24525741 DOI: 10.1158/0008-5472.CAN-12-0452] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
397 Rossi MR, Laduca J, Cowell JK, Srivastava BI, Matsui S. Genomic analysis of CD8+ NK/T cell line, 'SRIK-NKL', with array-based CGH (aCGH), SKY/FISH and molecular mapping. Leuk Res 2008;32:455-63. [PMID: 17640729 DOI: 10.1016/j.leukres.2007.04.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
398 Banerjee P, Crawford L, Samuelson E, Feuer G. Hematopoietic stem cells and retroviral infection. Retrovirology 2010;7:8. [PMID: 20132553 DOI: 10.1186/1742-4690-7-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
399 Nandi A, Chakrabarti R. The many facets of Notch signaling in breast cancer: toward overcoming therapeutic resistance. Genes Dev 2020;34:1422-38. [PMID: 33872192 DOI: 10.1101/gad.342287.120] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
400 Li Z, Yu F, Ye W, Mao L, Huang J, Shao Y, Yan J, Yu W, Jin J, Wang J. Clinical Features and Prognostic Significance of NOTCH1 Mutations in Diffuse Large B-Cell Lymphoma. Front Oncol 2021;11:746577. [DOI: 10.3389/fonc.2021.746577] [Reference Citation Analysis]
401 Nyman PE, Buehler D, Lambert PF. Loss of Function of Canonical Notch Signaling Drives Head and Neck Carcinogenesis. Clin Cancer Res 2018;24:6308-18. [PMID: 30087145 DOI: 10.1158/1078-0432.CCR-17-3535] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
402 Wang F, Zhou H, Yang Y, Xia X, Sun Q, Luo J, Cheng B. Hepatitis B virus X protein promotes the growth of hepatocellular carcinoma by modulation of the Notch signaling pathway. Oncol Rep. 2012;27:1170-1176. [PMID: 22218807 DOI: 10.3892/or.2012.1620] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
403 Blanco R, Gerhardt H. VEGF and Notch in tip and stalk cell selection. Cold Spring Harb Perspect Med 2013;3:a006569. [PMID: 23085847 DOI: 10.1101/cshperspect.a006569] [Cited by in Crossref: 275] [Cited by in F6Publishing: 252] [Article Influence: 30.6] [Reference Citation Analysis]
404 El-Mallawany NK, Frazer JK, Van Vlierberghe P, Ferrando AA, Perkins S, Lim M, Chu Y, Cairo MS. Pediatric T- and NK-cell lymphomas: new biologic insights and treatment strategies. Blood Cancer J 2012;2:e65. [PMID: 22829967 DOI: 10.1038/bcj.2012.8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
405 Brennan K, Brown AM. Is there a role for Notch signalling in human breast cancer? Breast Cancer Res 2003;5:69-75. [PMID: 12631384 DOI: 10.1186/bcr559] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 1.8] [Reference Citation Analysis]
406 Bajaj J, Diaz E, Reya T. Stem cells in cancer initiation and progression. J Cell Biol. 2020;219. [PMID: 31874116 DOI: 10.1083/jcb.201911053] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 8.5] [Reference Citation Analysis]
407 Masuya M, Katayama N, Hoshino N, Nishikawa H, Sakano S, Araki H, Mitani H, Suzuki H, Miyashita H, Kobayashi K, Nishii K, Minami N, Shiku H. The soluble Notch ligand, Jagged-1, inhibits proliferation of CD34+ macrophage progenitors. Int J Hematol 2002;75:269-76. [PMID: 11999354 DOI: 10.1007/BF02982040] [Cited by in Crossref: 32] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
408 De Strooper B, Iwatsubo T, Wolfe MS. Presenilins and γ-secretase: structure, function, and role in Alzheimer Disease. Cold Spring Harb Perspect Med 2012;2:a006304. [PMID: 22315713 DOI: 10.1101/cshperspect.a006304] [Cited by in Crossref: 260] [Cited by in F6Publishing: 247] [Article Influence: 28.9] [Reference Citation Analysis]
409 Schroeder T, Just U. Notch signalling via RBP-J promotes myeloid differentiation. EMBO J 2000;19:2558-68. [PMID: 10835354 DOI: 10.1093/emboj/19.11.2558] [Cited by in Crossref: 103] [Cited by in F6Publishing: 101] [Article Influence: 4.7] [Reference Citation Analysis]
410 Hu C, Diévart A, Lupien M, Calvo E, Tremblay G, Jolicoeur P. Overexpression of activated murine Notch1 and Notch3 in transgenic mice blocks mammary gland development and induces mammary tumors. Am J Pathol 2006;168:973-90. [PMID: 16507912 DOI: 10.2353/ajpath.2006.050416] [Cited by in Crossref: 124] [Cited by in F6Publishing: 123] [Article Influence: 7.8] [Reference Citation Analysis]
411 Guo H, Lu Y, Wang J, Liu X, Keller ET, Liu Q, Zhou Q, Zhang J. Targeting the Notch signaling pathway in cancer therapeutics. Thorac Cancer 2014;5:473-86. [PMID: 26767041 DOI: 10.1111/1759-7714.12143] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
412 Alaña L, Sesé M, Cánovas V, Punyal Y, Fernández Y, Abasolo I, de Torres I, Ruiz C, Espinosa L, Bigas A, Y Cajal SR, Fernández PL, Serras F, Corominas M, Thomson TM, Paciucci R. Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch targets genes and promotes prostate cancer progression. Mol Cancer 2014;13:74. [PMID: 24684754 DOI: 10.1186/1476-4598-13-74] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
413 Mäkelä-Bengs P, Järvinen N, Vuopala K, Suomalainen A, Ignatius J, Sipilä M, Herva R, Palotie A, Peltonen L. Assignment of the disease locus for lethal congenital contracture syndrome to a restricted region of chromosome 9q34, by genome scan using five affected individuals. Am J Hum Genet 1998;63:506-16. [PMID: 9683599 DOI: 10.1086/301968] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 1.6] [Reference Citation Analysis]
414 Reymond A, Schmidt S, Simanis V. Mutations in the cdc10 start gene of Schizosaccharomyces pombe implicate the region of homology between cdc10 and SWI6 as important for p85cdc10 function. Mol Gen Genet 1992;234:449-56. [PMID: 1406591 DOI: 10.1007/BF00538705] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
415 Friedrich MJ, Rad L, Bronner IF, Strong A, Wang W, Weber J, Mayho M, Ponstingl H, Engleitner T, Grove C, Pfaus A, Saur D, Cadiñanos J, Quail MA, Vassiliou GS, Liu P, Bradley A, Rad R. Genome-wide transposon screening and quantitative insertion site sequencing for cancer gene discovery in mice. Nat Protoc 2017;12:289-309. [PMID: 28079877 DOI: 10.1038/nprot.2016.164] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
416 Gonzalez C. Drosophila melanogaster: a model and a tool to investigate malignancy and identify new therapeutics. Nat Rev Cancer 2013;13:172-83. [PMID: 23388617 DOI: 10.1038/nrc3461] [Cited by in Crossref: 183] [Cited by in F6Publishing: 163] [Article Influence: 20.3] [Reference Citation Analysis]
417 Watanabe S, Ito J, Baba T, Hiratsuka T, Kuse K, Ochi H, Anai Y, Hisasue M, Tsujimoto H, Nishigaki K. Notch2 transduction by feline leukemia virus in a naturally infected cat. J Vet Med Sci 2014;76:553-7. [PMID: 24317268 DOI: 10.1292/jvms.13-0344] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
418 Roti G, Carlton A, Ross KN, Markstein M, Pajcini K, Su AH, Perrimon N, Pear WS, Kung AL, Blacklow SC, Aster JC, Stegmaier K. Complementary genomic screens identify SERCA as a therapeutic target in NOTCH1 mutated cancer. Cancer Cell 2013;23:390-405. [PMID: 23434461 DOI: 10.1016/j.ccr.2013.01.015] [Cited by in Crossref: 90] [Cited by in F6Publishing: 89] [Article Influence: 10.0] [Reference Citation Analysis]
419 Palomero T, Dominguez M, Ferrando AA. The role of the PTEN/AKT Pathway in NOTCH1-induced leukemia. Cell Cycle 2008;7:965-70. [PMID: 18414037 DOI: 10.4161/cc.7.8.5753] [Cited by in Crossref: 171] [Cited by in F6Publishing: 164] [Article Influence: 12.2] [Reference Citation Analysis]
420 Piazzi G, Bazzoli F, Ricciardiello L. Epigenetic silencing of Notch signaling in gastrointestinal cancers. Cell Cycle 2012;11:4323-7. [PMID: 23085543 DOI: 10.4161/cc.22388] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
421 Krantz ID, Colliton RP, Genin A, Rand EB, Li L, Piccoli DA, Spinner NB. Spectrum and frequency of jagged1 (JAG1) mutations in Alagille syndrome patients and their families. Am J Hum Genet 1998;62:1361-9. [PMID: 9585603 DOI: 10.1086/301875] [Cited by in Crossref: 156] [Cited by in F6Publishing: 133] [Article Influence: 6.5] [Reference Citation Analysis]
422 Shen H, Suzuki T, Munroe DJ, Stewart C, Rasmussen L, Gilbert DJ, Jenkins NA, Copeland NG. Common sites of retroviral integration in mouse hematopoietic tumors identified by high-throughput, single nucleotide polymorphism-based mapping and bacterial artificial chromosome hybridization. J Virol 2003;77:1584-8. [PMID: 12502872 DOI: 10.1128/jvi.77.2.1584-1588.2003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
423 Sulis ML, Williams O, Palomero T, Tosello V, Pallikuppam S, Real PJ, Barnes K, Zuurbier L, Meijerink JP, Ferrando AA. NOTCH1 extracellular juxtamembrane expansion mutations in T-ALL. Blood 2008;112:733-40. [PMID: 18411416 DOI: 10.1182/blood-2007-12-130096] [Cited by in Crossref: 90] [Cited by in F6Publishing: 88] [Article Influence: 6.4] [Reference Citation Analysis]
424 Zhao D, Mo Y, Li MT, Zou SW, Cheng ZL, Sun YP, Xiong Y, Guan KL, Lei QY. NOTCH-induced aldehyde dehydrogenase 1A1 deacetylation promotes breast cancer stem cells. J Clin Invest. 2014;124:5453-5465. [PMID: 25384215 DOI: 10.1172/jci76611] [Cited by in Crossref: 89] [Cited by in F6Publishing: 63] [Article Influence: 11.1] [Reference Citation Analysis]
425 Shimizu K, Chiba S, Hosoya N, Kumano K, Saito T, Kurokawa M, Kanda Y, Hamada Y, Hirai H. Binding of Delta1, Jagged1, and Jagged2 to Notch2 rapidly induces cleavage, nuclear translocation, and hyperphosphorylation of Notch2. Mol Cell Biol 2000;20:6913-22. [PMID: 10958687 DOI: 10.1128/MCB.20.18.6913-6922.2000] [Cited by in Crossref: 130] [Cited by in F6Publishing: 45] [Article Influence: 5.9] [Reference Citation Analysis]
426 Shimizu K, Chiba S, Saito T, Takahashi T, Kumano K, Hamada Y, Hirai H. Integrity of intracellular domain of Notch ligand is indispensable for cleavage required for release of the Notch2 intracellular domain. EMBO J 2002;21:294-302. [PMID: 11823422 DOI: 10.1093/emboj/21.3.294] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 2.6] [Reference Citation Analysis]
427 Kordbacheh F, Farah CS. Molecular Pathways and Druggable Targets in Head and Neck Squamous Cell Carcinoma. Cancers (Basel) 2021;13:3453. [PMID: 34298667 DOI: 10.3390/cancers13143453] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
428 Zhu P, Wang Y, Du Y, He L, Huang G, Zhang G, Yan X, Fan Z. C8orf4 negatively regulates self-renewal of liver cancer stem cells via suppression of NOTCH2 signalling. Nat Commun 2015;6:7122. [PMID: 25985737 DOI: 10.1038/ncomms8122] [Cited by in Crossref: 70] [Cited by in F6Publishing: 73] [Article Influence: 10.0] [Reference Citation Analysis]
429 Zhou S, Fujimuro M, Hsieh JJ, Chen L, Miyamoto A, Weinmaster G, Hayward SD. SKIP, a CBF1-associated protein, interacts with the ankyrin repeat domain of NotchIC To facilitate NotchIC function. Mol Cell Biol. 2000;20:2400-2410. [PMID: 10713164 DOI: 10.1128/mcb.20.7.2400-2410.2000] [Cited by in Crossref: 183] [Cited by in F6Publishing: 86] [Article Influence: 8.3] [Reference Citation Analysis]
430 Ross DA, Rao PK, Kadesch T. Dual roles for the Notch target gene Hes-1 in the differentiation of 3T3-L1 preadipocytes. Mol Cell Biol 2004;24:3505-13. [PMID: 15060169 DOI: 10.1128/MCB.24.8.3505-3513.2004] [Cited by in Crossref: 107] [Cited by in F6Publishing: 67] [Article Influence: 5.9] [Reference Citation Analysis]
431 Gragnani L, Lorini S, Marri S, Zignego AL. Role of Notch Receptors in Hematologic Malignancies. Cells 2020;10:E16. [PMID: 33374160 DOI: 10.3390/cells10010016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
432 Kiel MJ, Velusamy T, Betz BL, Zhao L, Weigelin HG, Chiang MY, Huebner-Chan DR, Bailey NG, Yang DT, Bhagat G, Miranda RN, Bahler DW, Medeiros LJ, Lim MS, Elenitoba-Johnson KS. Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma. J Exp Med 2012;209:1553-65. [PMID: 22891276 DOI: 10.1084/jem.20120910] [Cited by in Crossref: 204] [Cited by in F6Publishing: 178] [Article Influence: 20.4] [Reference Citation Analysis]
433 Groeneweg JW, Foster R, Growdon WB, Verheijen RH, Rueda BR. Notch signaling in serous ovarian cancer. J Ovarian Res 2014;7:95. [PMID: 25366565 DOI: 10.1186/s13048-014-0095-1] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 6.0] [Reference Citation Analysis]
434 Sharif A, Shaji A, Chammaa M, Pawlik E, Fernandez-Valdivia R. Notch Transduction in Non-Small Cell Lung Cancer. Int J Mol Sci 2020;21:E5691. [PMID: 32784481 DOI: 10.3390/ijms21165691] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
435 Chen CF, Dou XW, Liang YK, Lin HY, Bai JW, Zhang XX, Wei XL, Li YC, Zhang GJ. Notch3 overexpression causes arrest of cell cycle progression by inducing Cdh1 expression in human breast cancer cells. Cell Cycle 2016;15:432-40. [PMID: 26694515 DOI: 10.1080/15384101.2015.1127474] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
436 Bendari M, Bencharef H, Khoubila N, Cherkaoui S, Lamchahab M, Madani A, Rachid M, Qachouh M, Oukache B, Quessar A. Secondary Thymoma among Adult Treated For Acute Lymphoblastic Lymphoma/Leukemia: Report of a Case and Review of the Literature. Open Access Maced J Med Sci 2018;6:2373-5. [PMID: 30607194 DOI: 10.3889/oamjms.2018.396] [Reference Citation Analysis]
437 Giovannini C, Bolondi L, Gramantieri L. Targeting Notch3 in Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Perspectives. Int J Mol Sci. 2016;18. [PMID: 28036048 DOI: 10.3390/ijms18010056] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
438 Aster JC, Pear WS, Blacklow SC. Notch signaling in leukemia. Annu Rev Pathol 2008;3:587-613. [PMID: 18039126 DOI: 10.1146/annurev.pathmechdis.3.121806.154300] [Cited by in Crossref: 185] [Cited by in F6Publishing: 185] [Article Influence: 13.2] [Reference Citation Analysis]
439 Condorelli AG, El Hachem M, Zambruno G, Nystrom A, Candi E, Castiglia D. Notch-ing up knowledge on molecular mechanisms of skin fibrosis: focus on the multifaceted Notch signalling pathway. J Biomed Sci 2021;28:36. [PMID: 33966637 DOI: 10.1186/s12929-021-00732-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
440 Banerjee D, Hernandez SL, Garcia A, Kangsamaksin T, Sbiroli E, Andrews J, Forrester LA, Wei N, Kadenhe-Chiweshe A, Shawber CJ, Kitajewski JK, Kandel JJ, Yamashiro DJ. Notch suppresses angiogenesis and progression of hepatic metastases. Cancer Res 2015;75:1592-602. [PMID: 25744722 DOI: 10.1158/0008-5472.CAN-14-1493] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
441 Kumar A, Balbach J. Folding and Stability of Ankyrin Repeats Control Biological Protein Function. Biomolecules 2021;11:840. [PMID: 34198779 DOI: 10.3390/biom11060840] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
442 Yugawa T, Handa K, Narisawa-Saito M, Ohno S, Fujita M, Kiyono T. Regulation of Notch1 gene expression by p53 in epithelial cells. Mol Cell Biol 2007;27:3732-42. [PMID: 17353266 DOI: 10.1128/MCB.02119-06] [Cited by in Crossref: 124] [Cited by in F6Publishing: 87] [Article Influence: 8.3] [Reference Citation Analysis]
443 Huang R, Tang Q, You Q, Liu Z, Wang G, Chen Y, Sun Y, Muhammad S, Wang X. Disparity expression of Notch1 in benign and malignant colorectal diseases. PLoS One 2013;8:e81005. [PMID: 24312514 DOI: 10.1371/journal.pone.0081005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
444 Rand MD, Grimm LM, Artavanis-Tsakonas S, Patriub V, Blacklow SC, Sklar J, Aster JC. Calcium depletion dissociates and activates heterodimeric notch receptors. Mol Cell Biol 2000;20:1825-35. [PMID: 10669757 DOI: 10.1128/MCB.20.5.1825-1835.2000] [Cited by in Crossref: 280] [Cited by in F6Publishing: 153] [Article Influence: 12.7] [Reference Citation Analysis]
445 Zhang K, Wong P, Zhang L, Jacobs B, Borden EC, Aster JC, Bedogni B. A Notch1-neuregulin1 autocrine signaling loop contributes to melanoma growth. Oncogene 2012;31:4609-18. [PMID: 22249266 DOI: 10.1038/onc.2011.606] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]
446 Berquam-Vrieze KE, Swing DA, Tessarollo L, Dupuy AJ. Characterization of transgenic mice expressing cancer-associated variants of human NOTCH1. Genesis 2012;50:112-8. [PMID: 21898766 DOI: 10.1002/dvg.20798] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
447 Pandey A, Li-Kroeger D, Sethi MK, Lee TV, Buettner FF, Bakker H, Jafar-Nejad H. Sensitized genetic backgrounds reveal differential roles for EGF repeat xylosyltransferases in Drosophila Notch signaling. Glycobiology 2018;28:849-59. [PMID: 30169771 DOI: 10.1093/glycob/cwy080] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
448 Dudley DD, Wang HC, Sun XH. Hes1 potentiates T cell lymphomagenesis by up-regulating a subset of notch target genes. PLoS One 2009;4:e6678. [PMID: 19688092 DOI: 10.1371/journal.pone.0006678] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
449 Weng AP, Nam Y, Wolfe MS, Pear WS, Griffin JD, Blacklow SC, Aster JC. Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling. Mol Cell Biol 2003;23:655-64. [PMID: 12509463 DOI: 10.1128/MCB.23.2.655-664.2003] [Cited by in Crossref: 284] [Cited by in F6Publishing: 176] [Article Influence: 14.9] [Reference Citation Analysis]
450 Robbins J, Blondel BJ, Gallahan D, Callahan R. Mouse mammary tumor gene int-3: a member of the notch gene family transforms mammary epithelial cells. J Virol 1992;66:2594-9. [PMID: 1312643 DOI: 10.1128/JVI.66.4.2594-2599.1992] [Cited by in Crossref: 168] [Cited by in F6Publishing: 59] [Article Influence: 5.6] [Reference Citation Analysis]
451 Gu Y, Masiero M, Banham AH. Notch signaling: its roles and therapeutic potential in hematological malignancies. Oncotarget 2016;7:29804-23. [PMID: 26934331 DOI: 10.18632/oncotarget.7772] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 9.8] [Reference Citation Analysis]
452 Kuang SQ, Fang Z, Zweidler-McKay PA, Yang H, Wei Y, Gonzalez-Cervantes EA, Boumber Y, Garcia-Manero G. Epigenetic inactivation of Notch-Hes pathway in human B-cell acute lymphoblastic leukemia. PLoS One. 2013;8:e61807. [PMID: 23637910 DOI: 10.1371/journal.pone.0061807] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
453 Aster JC, Pear WS, Blacklow SC. The Varied Roles of Notch in Cancer. Annu Rev Pathol. 2017;12:245-275. [PMID: 27959635 DOI: 10.1146/annurev-pathol-052016-100127] [Cited by in Crossref: 238] [Cited by in F6Publishing: 228] [Article Influence: 39.7] [Reference Citation Analysis]
454 Bedogni B, Warneke JA, Nickoloff BJ, Giaccia AJ, Powell MB. Notch1 is an effector of Akt and hypoxia in melanoma development. J Clin Invest 2008;118:3660-70. [PMID: 18924608 DOI: 10.1172/JCI36157] [Cited by in Crossref: 159] [Cited by in F6Publishing: 83] [Article Influence: 11.4] [Reference Citation Analysis]
455 Séveno C, Loussouarn D, Bréchet S, Campone M, Juin P, Barillé-Nion S. γ-Secretase inhibition promotes cell death, Noxa upregulation, and sensitization to BH3 mimetic ABT-737 in human breast cancer cells. Breast Cancer Res 2012;14:R96. [PMID: 22703841 DOI: 10.1186/bcr3214] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
456 Idilli AI, Precazzini F, Mione MC, Anelli V. Zebrafish in Translational Cancer Research: Insight into Leukemia, Melanoma, Glioma and Endocrine Tumor Biology. Genes (Basel) 2017;8:E236. [PMID: 28930163 DOI: 10.3390/genes8090236] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
457 Ersvaer E, Hatfield KJ, Reikvam H, Bruserud O. Future perspectives: therapeutic targeting of notch signalling may become a strategy in patients receiving stem cell transplantation for hematologic malignancies. Bone Marrow Res 2011;2011:570796. [PMID: 22046566 DOI: 10.1155/2011/570796] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
458 Sahin IH, Iacobuzio-Donahue CA, O’Reilly EM. Molecular signature of pancreatic adenocarcinoma: an insight from genotype to phenotype and challenges for targeted therapy. Expert Opin Ther Targets. 2016;20:341-359. [PMID: 26439702 DOI: 10.1517/14728222.2016.1094057] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
459 Van Vlierberghe P, Ferrando A. The molecular basis of T cell acute lymphoblastic leukemia. J Clin Invest 2012;122:3398-406. [PMID: 23023710 DOI: 10.1172/JCI61269] [Cited by in Crossref: 301] [Cited by in F6Publishing: 185] [Article Influence: 30.1] [Reference Citation Analysis]
460 Lefort K, Mandinova A, Ostano P, Kolev V, Calpini V, Kolfschoten I, Devgan V, Lieb J, Raffoul W, Hohl D, Neel V, Garlick J, Chiorino G, Dotto GP. Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1/2 and MRCKalpha kinases. Genes Dev 2007;21:562-77. [PMID: 17344417 DOI: 10.1101/gad.1484707] [Cited by in Crossref: 215] [Cited by in F6Publishing: 209] [Article Influence: 14.3] [Reference Citation Analysis]
461 Lino MM, Merlo A, Boulay JL. Notch signaling in glioblastoma: a developmental drug target? BMC Med. 2010;8:72. [PMID: 21078177 DOI: 10.1186/1741-7015-8-72] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 4.5] [Reference Citation Analysis]
462 Wu K, Zhang L, Lin Y, Yang K, Cheng Y. Inhibition of γ-secretase induces G2/M arrest and triggers apoptosis in renal cell carcinoma. Oncol Lett 2014;8:55-61. [PMID: 24959218 DOI: 10.3892/ol.2014.2078] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
463 Allen F, Maillard I. Therapeutic Targeting of Notch Signaling: From Cancer to Inflammatory Disorders. Front Cell Dev Biol 2021;9:649205. [PMID: 34124039 DOI: 10.3389/fcell.2021.649205] [Reference Citation Analysis]
464 Yoon HA, Noh MH, Kim BG, Han JS, Jang JS, Choi SR, Jeong JS, Chun JH. Clinicopathological significance of altered Notch signaling in extrahepatic cholangiocarcinoma and gallbladder carcinoma. World J Gastroenterol 2011; 17(35): 4023-4030 [PMID: 22046092 DOI: 10.3748/wjg.v17.i35.4023] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
465 Manfè V, Biskup E, Rosbjerg A, Kamstrup M, Skov AG, Lerche CM, Lauenborg BT, Odum N, Gniadecki R. miR-122 regulates p53/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma. PLoS One 2012;7:e29541. [PMID: 22235305 DOI: 10.1371/journal.pone.0029541] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 7.3] [Reference Citation Analysis]
466 Roti G, Stegmaier K. New Approaches to Target T-ALL. Front Oncol 2014;4:170. [PMID: 25072021 DOI: 10.3389/fonc.2014.00170] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
467 Gridley T. Twenty Years in Maine: Integrating Insights from Developmental Biology into Translational Medicine in a Small State. Curr Top Dev Biol 2016;116:435-43. [PMID: 26970632 DOI: 10.1016/bs.ctdb.2015.10.004] [Reference Citation Analysis]
468 Larson Gedman A, Chen Q, Kugel Desmoulin S, Ge Y, LaFiura K, Haska CL, Cherian C, Devidas M, Linda SB, Taub JW, Matherly LH. The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group. Leukemia 2009;23:1417-25. [PMID: 19340001 DOI: 10.1038/leu.2009.64] [Cited by in Crossref: 97] [Cited by in F6Publishing: 100] [Article Influence: 7.5] [Reference Citation Analysis]
469 Dobrovinskaya O, Delgado-Enciso I, Quintero-Castro LJ, Best-Aguilera C, Rojas-Sotelo RM, Pottosin I. Placing ion channels into a signaling network of T cells: from maturing thymocytes to healthy T lymphocytes or leukemic T lymphoblasts. Biomed Res Int 2015;2015:750203. [PMID: 25866806 DOI: 10.1155/2015/750203] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
470 Das T, Zhong R, Spiotto MT. Notch Signaling and Human Papillomavirus-Associated Oral Tumorigenesis. Adv Exp Med Biol 2021;1287:105-22. [PMID: 33034029 DOI: 10.1007/978-3-030-55031-8_8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
471 Lee-Sherick AB, Linger RM, Gore L, Keating AK, Graham DK. Targeting paediatric acute lymphoblastic leukaemia: novel therapies currently in development. Br J Haematol 2010;151:295-311. [PMID: 20813012 DOI: 10.1111/j.1365-2141.2010.08282.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
472 Pear WS, Aster JC, Scott ML, Hasserjian RP, Soffer B, Sklar J, Baltimore D. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J Exp Med 1996;183:2283-91. [PMID: 8642337 DOI: 10.1084/jem.183.5.2283] [Cited by in Crossref: 529] [Cited by in F6Publishing: 505] [Article Influence: 20.3] [Reference Citation Analysis]
473 Mittal S, Subramanyam D, Dey D, Kumar RV, Rangarajan A. Cooperation of Notch and Ras/MAPK signaling pathways in human breast carcinogenesis. Mol Cancer. 2009;8:128. [PMID: 20030805 DOI: 10.1186/1476-4598-8-128] [Cited by in Crossref: 93] [Cited by in F6Publishing: 86] [Article Influence: 7.2] [Reference Citation Analysis]
474 Kiaris H, Politi K, Grimm LM, Szabolcs M, Fisher P, Efstratiadis A, Artavanis-Tsakonas S. Modulation of notch signaling elicits signature tumors and inhibits hras1-induced oncogenesis in the mouse mammary epithelium. Am J Pathol 2004;165:695-705. [PMID: 15277242 DOI: 10.1016/S0002-9440(10)63333-0] [Cited by in Crossref: 92] [Cited by in F6Publishing: 49] [Article Influence: 5.1] [Reference Citation Analysis]
475 Jafar-Nejad H, Leonardi J, Fernandez-Valdivia R. Role of glycans and glycosyltransferases in the regulation of Notch signaling. Glycobiology 2010;20:931-49. [PMID: 20368670 DOI: 10.1093/glycob/cwq053] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 4.5] [Reference Citation Analysis]
476 Jensen CH, Jauho EI, Santoni-Rugiu E, Holmskov U, Teisner B, Tygstrup N, Bisgaard HC. Transit-amplifying ductular (oval) cells and their hepatocytic progeny are characterized by a novel and distinctive expression of delta-like protein/preadipocyte factor 1/fetal antigen 1. Am J Pathol. 2004;164:1347-1359. [PMID: 15039222 DOI: 10.1016/s0002-9440(10)63221-x] [Cited by in Crossref: 104] [Cited by in F6Publishing: 39] [Article Influence: 5.8] [Reference Citation Analysis]
477 Ma J, Wu M. The indicative effect of Notch1 expression for the prognosis of T-cell acute lymphocytic leukemia: a systematic review. Mol Biol Rep 2012;39:6095-100. [PMID: 22311010 DOI: 10.1007/s11033-011-1424-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
478 Luo B, Aster JC, Hasserjian RP, Kuo F, Sklar J. Isolation and functional analysis of a cDNA for human Jagged2, a gene encoding a ligand for the Notch1 receptor. Mol Cell Biol 1997;17:6057-67. [PMID: 9315665 DOI: 10.1128/MCB.17.10.6057] [Cited by in Crossref: 154] [Cited by in F6Publishing: 53] [Article Influence: 6.2] [Reference Citation Analysis]